CN106110186A - A kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift - Google Patents
A kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift Download PDFInfo
- Publication number
- CN106110186A CN106110186A CN201610575042.7A CN201610575042A CN106110186A CN 106110186 A CN106110186 A CN 106110186A CN 201610575042 A CN201610575042 A CN 201610575042A CN 106110186 A CN106110186 A CN 106110186A
- Authority
- CN
- China
- Prior art keywords
- parts
- tumor
- radix
- blood
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 172
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 124
- 230000012010 growth Effects 0.000 title claims abstract description 39
- 230000000259 anti-tumor effect Effects 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 229940079593 drug Drugs 0.000 claims abstract description 45
- 239000009636 Huang Qi Substances 0.000 claims abstract description 40
- 210000003038 endothelium Anatomy 0.000 claims abstract description 36
- 241000522620 Scorpio Species 0.000 claims abstract description 30
- 239000009490 scorpio Substances 0.000 claims abstract description 30
- 210000000582 semen Anatomy 0.000 claims description 58
- 238000012546 transfer Methods 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 239000007779 soft material Substances 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 102000011759 adducin Human genes 0.000 claims description 2
- 108010076723 adducin Proteins 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000000643 oven drying Methods 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 58
- 239000008280 blood Substances 0.000 abstract description 57
- 231100000614 poison Toxicity 0.000 abstract description 50
- 210000000952 spleen Anatomy 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 29
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 28
- 210000004072 lung Anatomy 0.000 abstract description 28
- 201000010099 disease Diseases 0.000 abstract description 25
- 210000003734 kidney Anatomy 0.000 abstract description 22
- 230000001717 pathogenic effect Effects 0.000 abstract description 21
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 20
- 208000026435 phlegm Diseases 0.000 abstract description 20
- 230000007812 deficiency Effects 0.000 abstract description 18
- 244000052769 pathogen Species 0.000 abstract description 17
- 239000003440 toxic substance Substances 0.000 abstract description 12
- 230000036461 convulsion Effects 0.000 abstract description 8
- 206010010904 Convulsion Diseases 0.000 abstract description 7
- 230000009471 action Effects 0.000 abstract description 7
- 208000002173 dizziness Diseases 0.000 abstract description 7
- 238000005728 strengthening Methods 0.000 abstract description 7
- 230000007096 poisonous effect Effects 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 230000001914 calming effect Effects 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 241000721047 Danaus plexippus Species 0.000 abstract description 4
- 238000009825 accumulation Methods 0.000 abstract description 4
- 238000001035 drying Methods 0.000 abstract description 4
- 206010015037 epilepsy Diseases 0.000 abstract description 3
- 208000021760 high fever Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 238000011282 treatment Methods 0.000 description 59
- 238000002512 chemotherapy Methods 0.000 description 49
- 206010027476 Metastases Diseases 0.000 description 45
- 238000000034 method Methods 0.000 description 40
- 230000009401 metastasis Effects 0.000 description 32
- 239000002574 poison Substances 0.000 description 32
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 29
- 201000011510 cancer Diseases 0.000 description 28
- 210000004185 liver Anatomy 0.000 description 27
- 208000024891 symptom Diseases 0.000 description 27
- 230000014509 gene expression Effects 0.000 description 25
- 206010011224 Cough Diseases 0.000 description 23
- 230000002980 postoperative effect Effects 0.000 description 23
- 230000008859 change Effects 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 20
- 239000003172 expectorant agent Substances 0.000 description 20
- 230000003419 expectorant effect Effects 0.000 description 20
- 210000002966 serum Anatomy 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 18
- 230000036407 pain Effects 0.000 description 18
- 201000005202 lung cancer Diseases 0.000 description 17
- 208000020816 lung neoplasm Diseases 0.000 description 17
- 238000011160 research Methods 0.000 description 16
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 14
- 230000008569 process Effects 0.000 description 14
- 241000699666 Mus <mouse, genus> Species 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 239000010271 massa medicata fermentata Substances 0.000 description 12
- 230000008506 pathogenesis Effects 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 210000000481 breast Anatomy 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 11
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 10
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 10
- 230000033115 angiogenesis Effects 0.000 description 10
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 10
- 238000001959 radiotherapy Methods 0.000 description 10
- 206010006187 Breast cancer Diseases 0.000 description 9
- 208000026310 Breast neoplasm Diseases 0.000 description 9
- 244000178320 Vaccaria pyramidata Species 0.000 description 9
- 235000010587 Vaccaria pyramidata Nutrition 0.000 description 9
- 230000036528 appetite Effects 0.000 description 9
- 235000019789 appetite Nutrition 0.000 description 9
- 235000005911 diet Nutrition 0.000 description 9
- 230000037213 diet Effects 0.000 description 9
- 210000001835 viscera Anatomy 0.000 description 9
- 239000011800 void material Substances 0.000 description 9
- 101100243447 Arabidopsis thaliana PER53 gene Proteins 0.000 description 8
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 8
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 8
- 101150080074 TP53 gene Proteins 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 8
- 208000010553 multiple abscesses Diseases 0.000 description 8
- 230000001575 pathological effect Effects 0.000 description 8
- 230000002685 pulmonary effect Effects 0.000 description 8
- 230000001629 suppression Effects 0.000 description 8
- 241000756943 Codonopsis Species 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 206010061876 Obstruction Diseases 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 210000004881 tumor cell Anatomy 0.000 description 7
- 208000017667 Chronic Disease Diseases 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 201000008275 breast carcinoma Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 208000017574 dry cough Diseases 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 230000036737 immune function Effects 0.000 description 6
- 230000007170 pathology Effects 0.000 description 6
- 230000007958 sleep Effects 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 206010008479 Chest Pain Diseases 0.000 description 5
- 241001489978 Eupolyphaga Species 0.000 description 5
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 5
- 206010027458 Metastases to lung Diseases 0.000 description 5
- 241001250596 Pleione Species 0.000 description 5
- 230000004596 appetite loss Effects 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 201000006549 dyspepsia Diseases 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 235000008216 herbs Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 201000007270 liver cancer Diseases 0.000 description 5
- 208000014018 liver neoplasm Diseases 0.000 description 5
- 208000019017 loss of appetite Diseases 0.000 description 5
- 235000021266 loss of appetite Nutrition 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 101100372758 Danio rerio vegfaa gene Proteins 0.000 description 4
- 206010014080 Ecchymosis Diseases 0.000 description 4
- 239000009526 Fructus Akebiae Substances 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 101150030763 Vegfa gene Proteins 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 208000019790 abdominal distention Diseases 0.000 description 4
- 230000003187 abdominal effect Effects 0.000 description 4
- 239000002870 angiogenesis inducing agent Substances 0.000 description 4
- 108010052008 colla corii asini Proteins 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 210000002751 lymph Anatomy 0.000 description 4
- 210000005259 peripheral blood Anatomy 0.000 description 4
- 239000011886 peripheral blood Substances 0.000 description 4
- 238000004393 prognosis Methods 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 244000077995 Coix lacryma jobi Species 0.000 description 3
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 3
- 208000006402 Ductal Carcinoma Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010040007 Sense of oppression Diseases 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000002001 anti-metastasis Effects 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000005059 dormancy Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 210000001165 lymph node Anatomy 0.000 description 3
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 3
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- 238000007086 side reaction Methods 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000005747 tumor angiogenesis Effects 0.000 description 3
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 235000006487 Euryale ferox Nutrition 0.000 description 2
- 244000268590 Euryale ferox Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 101000979629 Homo sapiens Nucleoside diphosphate kinase A Proteins 0.000 description 2
- 208000008839 Kidney Neoplasms Diseases 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 241000244155 Taenia Species 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 206010064390 Tumour invasion Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000002491 angiogenic effect Effects 0.000 description 2
- 230000000118 anti-neoplastic effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000009045 body homeostasis Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000009400 cancer invasion Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000009104 chemotherapy regimen Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 210000005161 hepatic lobe Anatomy 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 238000002350 laparotomy Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000011866 long-term treatment Methods 0.000 description 2
- 201000005296 lung carcinoma Diseases 0.000 description 2
- 210000005265 lung cell Anatomy 0.000 description 2
- 201000000014 lung giant cell carcinoma Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 210000005015 mediastinal lymph node Anatomy 0.000 description 2
- 206010061289 metastatic neoplasm Diseases 0.000 description 2
- 210000004088 microvessel Anatomy 0.000 description 2
- 238000011275 oncology therapy Methods 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 201000005665 thrombophilia Diseases 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- VEEGZPWAAPPXRB-BJMVGYQFSA-N (3e)-3-(1h-imidazol-5-ylmethylidene)-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C/C1=CN=CN1 VEEGZPWAAPPXRB-BJMVGYQFSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000489492 Arisaema Species 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 241001649190 Campsis Species 0.000 description 1
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 241000045500 Diseae Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027457 Metastases to liver Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 241000736919 Pelodiscus sinensis Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041067 Small cell lung cancer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 239000010329 Xiangshaliujunzi decoction Substances 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229940121369 angiogenesis inhibitor Drugs 0.000 description 1
- 239000004037 angiogenesis inhibitor Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000011254 conventional chemotherapy Methods 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007905 drug manufacturing Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000001544 dysphoric effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000012820 exploratory laparotomy Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 239000009969 fructus bruceae Substances 0.000 description 1
- 238000013110 gastrectomy Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 102000057305 human giant cell Human genes 0.000 description 1
- 108700016261 human giant cell Proteins 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000012308 immunohistochemistry method Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000005917 in vivo anti-tumor Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000009731 jinlong Substances 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229960001756 oxaliplatin Drugs 0.000 description 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 201000002094 pancreatic adenocarcinoma Diseases 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- QOFFJEBXNKRSPX-ZDUSSCGKSA-N pemetrexed Chemical compound C1=N[C]2NC(N)=NC(=O)C2=C1CCC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QOFFJEBXNKRSPX-ZDUSSCGKSA-N 0.000 description 1
- 229960005079 pemetrexed Drugs 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001830 phrenic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 238000011248 postoperative chemotherapy Methods 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 208000000649 small cell carcinoma Diseases 0.000 description 1
- 208000000587 small cell lung carcinoma Diseases 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000011521 systemic chemotherapy Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940005186 tamoxifen 10 mg Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 229940053867 xeloda Drugs 0.000 description 1
- 239000009128 xihuang Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, including: the Radix Astragali, Fructus Ligustri Lucidi, the Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Endothelium Corneum Gigeriae Galli, Semen Coicis, Herba Scutellariae Barbatae, Rhizoma Curcumae, Scorpio, Spina Gleditsiae, Concha Ostreae, Carapax Trionycis, Ramulus Uncariae Cum Uncis, Radix Glycyrrhizae Preparata.The present invention reuses the Radix Astragali, Fructus Ligustri Lucidi is monarch drug.The common gas of tumor post-operation patient, blood, yin, yang virtual loss, the Radix Astragali is monarch, can strongly invigorating primordial QI, lung benefiting spleen invigorating.For a long time and kidney, deficiency of kidney-essence, Fructus Ligustri Lucidi enriching yin and nourishing kidney, can be Kidney-Yin in the kidney invigorating, unit is so incensed that multiple, then disease is from removing.The Radix Astragali, Fructus Ligustri Lucidi two medicine match, and play QI and blood regulating negative and positive altogether, the merit of the body resistance strengthening and constitution consolidating.Ministerial drug is with Herba Scutellariae Barbatae, Rhizoma Curcumae, Spina Gleditsiae, Concha Ostreae, Carapax Trionycis heat-clearing and toxic substances removing, blood circulation promoting and dispersing pathogen accumulation.Scorpio, Ramulus Uncariae Cum Uncis treating the poisonous disease with poisonous drugs, calming wind and dredging collateral.Assistant is with the Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Endothelium Corneum Gigeriae Galli, Semen Coicis, the spleen strengthening and damp drying, dissipating phlegm and resolving masses.Make with Radix Glycyrrhizae Preparata coordinating the actions of various ingredients in a prescription.Full side has " Fuzheng Huoxue, detoxicating and resolving stagnation of pathogens, the effect of the only shifting that relieves dizziness, high fever, infantile convulsions, epilepsy, etc..
Description
Technical field
The present invention relates to a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, belong to Chinese medicine
Field.
Background technology
Malignant tumor is one of disease that harm human health is the most serious, and its sickness rate is in ascendant trend year by year.According to generation
Boundary's health organization (WHO) and American Society of Clinical Oncology (ASCO) statistics, the de novo cancer patient in the whole world is 10,000,000 people,
Die from the patient of cancer between 600~7,000,000, averagely account for the 12% of dead sum.Resident's common cause of death is being sent out
Reach state's household first (accounting for the 22.3% of total death toll), developing china household second (accounting for the 9.5% of total death toll).?
China, annual de novo cancer patient about 1,600,000, die from about the 1300000 of cancer.China's tumor mortality rate in 1997 is in city
Being 1,36/,100,000 populations, account for first of Disease causation, rural area is 1,08/,100,000, occupies second.Most important of which cancer
Disease is pulmonary carcinoma, gastric cancer, breast carcinoma, colorectal cancer, oral cancer, hepatocarcinoma, cervical cancer and the esophageal carcinoma.Tumor is to causing on patient body
Misery, the financial burden brought to family and the destruction causing social productive forces are difficult to the appraisal.Therefore, WHO and China
Cancer has been classified as one of emphasis problem being badly in need of solution by government.
Neoplasm metastasis (metastasis) is that tumor cell is sent out the process being far apart organ by original site, is that tumor is disliked
The most essential performance of property.Although the current operation to tumor, chemotherapy, radiotherapy, Non-surgical combined treatment have made great progress, but
Still fail to stop the infiltration of tumor, transfer process.Having conclusive evidence to show, the malignant tumor patient of more than 90% ultimately succumbs to swell
Tumor metastasis or recurrence, and shift and occur the most in early days.Therefore, transfer is the main cause that treatment of cancer is failed, controls transfer
It it is the key factor determining cancer patient's prognosis.Neoplasm metastasis be a multi-step, multifactor, polygenes comprehensive function extremely
Complicated dynamic changing process.Numerous studies confirm: new vessels is that malignant tumor quickly increases necessary prerequisite,
Also being a key step distally shifting of malignant tumor and channel, each step of neoplasm metastasis is all raw with the blood capillary of tumor
Become closely related.Therefore, suppression tumor-blood-vessel growth is prevention and controls the important channel that neoplasm metastasis occurs.With tumor
Vascularization is based on the metastasis research of target spot becomes and the focus of clinical research, finds new high-efficiency low-toxicity angiogenesis
Inhibitor has become the emphasis problem of current anti-metastasis drug research.
Chinese medicine has the status become more and more important in combined therapy of tumour, multi-level, too many levels, the Mutiple Targets of Chinese medicine
Mechanism of action feature, the treatment that exactly compensate for the single action target spot of Western medicine single component is often difficult to reach thoroughly to effect a radical cure effect
The shortcoming of fruit, the development for medicine for anti transfer of tumor provides a natural Drug Storage.Therefore, with traditional Chinese medicine theory for instructing
And combine with the modern study achievement of tumor-blood-vessel growth and transfer, exploitation has suppression tumor angiogenesis, blocking-up
The new Chinese medicine of neoplasm metastasis approach, for controlling tumor invasion, transfer, improves patient's prognosis and improves long-dated survival further
Rate tool is of great significance.
Summary of the invention
It is an object of the invention to, it is provided that a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, tool
There are " Fuzheng Huoxue, detoxicating and resolving stagnation of pathogens, the effect of the only shifting that relieves dizziness, high fever, infantile convulsions, epilepsy, etc..
Technical solution of the present invention is as follows: a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, with weight
Amount part meter, including the crude drug of following component: the Radix Astragali 45~60 parts, Fructus Ligustri Lucidi 15~30 parts, the Rhizoma Pinelliae 10~15 parts, Pericarpium Citri Reticulatae 10~
15 parts, Endothelium Corneum Gigeriae Galli 10~18 parts, Semen Coicis 18~30 parts, Herba Scutellariae Barbatae 20~30 parts, Rhizoma Curcumae 20~30 parts, Scorpio 10~15
Part, Spina Gleditsiae 10~15 parts, Concha Ostreae 30~60 parts, Carapax Trionycis 10~20 parts, Ramulus Uncariae Cum Uncis 10~15 parts, Radix Glycyrrhizae Preparata 6~10 parts.
Preparation method: be decocted in water for oral dose, potion on the one, divides and sooner or later takes for twice.
Chinese medicine composition of the present invention can also be prepared as the dosage forms such as Chinese medicine capsules, granule, tablet, powder, pill.
Transfer is the main cause that treatment of cancer is failed, and controlling transfer is the key factor determining cancer patient's prognosis.This
The purport of invention prescription is recurrence and the transfer of anti-curing oncoma.Inventors believe that tumor is a systemic disease, transfer is
The concrete manifestation of its generalization;Healthy energy virtual loss, the most not pressing down heresy is the basic reason that neoplasm metastasis occurs;Propose the deficiency of vital energy of transfer
Blood stasis, expectorant poison multiple abscess, the theory of pathogenesis of obstruction of collateral caused by windphlegm, the pathogenesis development law of transfer is healthy energy virtual loss, accumulates, in wind syndrome caused by deficiency in evil poison
Dynamic, wind holds expectorant poison under the arm, and multiple abscess meridians, the stasis of blood forms long-pending.Clinical application must be started with in terms of void, the stasis of blood, poison, expectorant, wet, wind etc., can treat
Effect is notable.
Therefore, the present invention reuses the Radix Astragali, Fructus Ligustri Lucidi is monarch drug.The common gas of tumor post-operation patient, blood, yin, yang virtual loss, the Radix Astragali
For monarch, can strongly invigorating primordial QI, lung benefiting spleen invigorating is sick.For a long time and kidney, deficiency of kidney-essence, Fructus Ligustri Lucidi enriching yin and nourishing kidney, can be Kidney-Yin in the kidney invigorating, unit is so incensed that
Multiple, then disease is from removing.The Radix Astragali, Fructus Ligustri Lucidi two medicine match, and play QI and blood regulating negative and positive altogether, the merit of the body resistance strengthening and constitution consolidating.Ministerial drug with Herba Scutellariae Barbatae,
Rhizoma Curcumae, Spina Gleditsiae, Concha Ostreae, Carapax Trionycis heat-clearing and toxic substances removing, blood circulation promoting and dispersing pathogen accumulation.Scorpio, Ramulus Uncariae Cum Uncis treating the poisonous disease with poisonous drugs, calming wind and dredging collateral.Help with the Rhizoma Pinelliae, old
Skin, Endothelium Corneum Gigeriae Galli, Semen Coicis, the spleen strengthening and damp drying, dissipating phlegm and resolving masses.Make with Radix Glycyrrhizae Preparata coordinating the actions of various ingredients in a prescription.
Specifically, in side of the present invention, the pharmacological action of each crude drug is as follows:
The Radix Astragali: nature and flavor are sweet, tepor.Return lung, spleen, liver, kidney channel.The special QI invigorating of Radix Astragali merit, lung benefiting spleen invigorating, there is invigorating QI to consolidate the body surface resistance,
Diuresis poison holding, evacuation of pus, the merit of expelling pus and promoting granulation, it is the function of its invigorating vital QI at all, since ancient times for the key medicine of righting.Existing
Generation research confirms the effect of the Radix Astragali: 1 strengthens immunologic function 2 promotees effect 3 enhancing body anoxia enduring and the stress ability 4 of interferon
Enter organism metabolism 5 to improve cardiac function 6 hypotensive effect 7 hepatoprotective effect 8 and regulate that blood glucose 9 is antibacterial and antiviral effect 10 hormonelike is made
With.
Fructus Ligustri Lucidi: sweet, bitter, cold.Return liver, kidney channel.Nourishing the liver and kidney, improving eyesight black hair.For vertigo and tinnitus, soreness of the waist and knees, palpus
Send out the whitest, poor vision.
Herba Scutellariae Barbatae: pungent, bitter, cold.Return lung, liver, kidney channel.Heat-clearing and toxic substances removing, blood stasis dispelling diuresis.For furuncle swelling toxin, laryngopharynx swelling and pain,
Venom, falls and flutters the pain of injury, edema, jaundice.
Rhizoma Curcumae: pungent, bitter, temperature.Return liver, spleen channel.Circulation of qi promoting removing blood stasis, removing food stagnancy pain relieving.For abdominal mass mass in the abdomen, blood stasis amenorrhea, food stagnation
Distending pain;Early cervical carcinoma.
Spina Gleditsiae: nature and flavor are pungent, temperature.Return liver, stomach warp.Detumescence poison holding, evacuation of pus, parasite killing.For carbuncle from the beginning of or difficulty in discharging of pus;
External treatment scabies leprosy
Concha Ostreae: salty, is slightly cold.Return liver, gallbladder, kidney channel.Tranquillization with heavy prescription, YANG hyperactivity suppressing nourishing YIN, hard masses softening and resolving.For insomnia of palpitating with fear, dizzy
Dizzy tinnitus, scrofula sucutaneous nodule, lump in the abdomen mass in the abdomen.Concha Ostreae (calcined) convergence is astringent or styptic treatment for spontaneous sweating.For spontaneous sweating, metrorrhagia and leukorrhagia of passing out semen, acid regurgitation of having a stomachache.
Carapax Trionycis: salty, is slightly cold.Return liver, kidney channel.Nourishing YIN for suppressing the hyperactive YANG, hard masses softening and resolving, bring down a fever except steaming.For fever due to yin deficiency, consumptive fever bone
Steam, stirring-up of pathogenic wind in the interior resulting from deficiency, amenorrhea, abdominal mass, chronic malaria malaria with splenomegaly.
Scorpio: pungent, flat;Poisonous.Return Liver Channel.Endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain.For infantile convulsion, tic convulsion
Contraction, middle air port is askew, hemiplegia, tetanus, rheumatoid arthritis stubborn, migraine and general headache, skin infection, scrofula.
Ramulus Uncariae Cum Uncis: sweet is cool.Return liver, pericardium channel.Heat clearing away suppressing the hyperactive liver, dispelling wind and relieving convulsion.For dizziness of having a headache, dysphoric cold, infantile convulsion is taken out
Jerk, pre-eclampsia;Hypertension.
The Rhizoma Pinelliae: pungent, temperature;Poisonous.Return spleen, stomach, lung meridian.Drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.For abundant expectoration cough with asthma,
Phlegm retention vertigo and palpitation, dizziness due to wind-phlegm, syncope due to accumulation of phlegm is had a headache, and vomits regurgitation, and breast gastral cavity painful abdominal mass is vexed, globus hystericus;Raw with external treatment carbuncle sucutaneous nodule.Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) is many
For stopping nausea and vomiting by lowering the adverse flow of QI.
Pericarpium Citri Reticulatae: bitter, pungent, temperature.Return lung, spleen channel.Regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.For fullness in the epigastrium and chest, lack of appetite and vomiting, cough
Abundant expectoration.
Endothelium Corneum Gigeriae Galli: sweet is flat.Return spleen, stomach, small intestinal, bladder warp.Invigorating the stomach and promoting digestion, arresting seminal emission.Do not disappear for food stagnation, vomiting
Dysentery, infantile malnutrition, the enuresis, seminal emission.
Semen Coicis: sweet, light is cool.Return spleen, stomach, lung meridian.Spleen invigorating eliminating dampness by diuresis, eliminating impediment antidiarrheal, row is dense in heat clearing away.For edema, foot
Gas, dysuria, arthralgia chiefly caused by damp pathogen contracture, diarrhea due to hypofunction of the spleen, lung abscess, acute appendicitis;Verruca plana.
Radix Glycyrrhizae: sweet, flat.GUIXIN, lung, spleen, stomach warp.Invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, it is in harmonious proportion all
Medicine.For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, extremity contraction urgency pain, carbuncle sore tumefacting virus, abirritant
Thing toxicity, strong.
There is advantages that medicament composing prescription of the present invention has significantly suppression tumor-blood-vessel growth and anti-rotation
Shifting recurrence effect, and notable prolongation tumor post-operation survival of patients phase, quality of making the life better, alleviate chemical therapy toxic side effect.Its effect
By reducing tumor and interstitial MVD thereof, suppression promotees the expression of tumor angiogenesis factor VEGF, BFGF, MMP-9, lowers sudden change
The expression of type P53 gene protein, improves anti-metastasis gene NM23 gene expression, improves that body height is viscous, hypercoagulability, protects
Protect body immune system, improve that cellular immune function etc. is multi-level, the multi-mechanism of too many levels, Mutiple Targets realizes.
Below in conjunction with Sero-pharmacological experiment, animal experiment in vivo, clinical research (rear attached clinical case), the present invention is imitated
Fruit is described further.
One, research purpose
Transfer is the main cause that treatment of cancer is failed, and controlling transfer is the key factor determining cancer patient's prognosis.Newly
Angiogenic is that malignant tumor quickly increases necessary prerequisite, is also a main step distally shifting of malignant tumor
Rapid and channel, each step of neoplasm metastasis is all closely related with the Angiogenesis of tumor.Therefore, suppression tumor-blood-vessel growth is
The important channel that prevention and control neoplasm metastasis occur.
This research, according to tumor-blood-vessel growth and the pathogenic characteristic of transfer " weakened body resistance blood stasis, evil poison multiple abscess, obstruction of collateral caused by windphlegm ", is intended
This medicament composing prescription of fixed " " Fuzheng Huoxue, detoxicating and resolving stagnation of pathogens, calming wind and dredging collateral ".Utilize modern medical research methods, respectively from different layers
Secondary, varying level, different angles illustrate the Antineoplastic angiogenesis of this medicament composing prescription and tumor suppression metastasis effect and mechanism, for the present
After the further extensively application of this medicine scientific basis is provided.
Two, research method and content
(1) basic research
1 experiment in vitro (Sero-pharmacological experiment)
1.1 medicament composing prescription Contained Serums of the present invention, the preparation of normal mouse serum
Wistar rat is randomly divided into 2 groups, and Contained Serum group gives medicament composing prescription aqueous solution of the present invention every day, and (every milliliter contains
Crude drug 2 grams) 3ml/ time, 3 times/day of gavages, blank serum group gives normal saline gavage every day, in being administered the 3rd day, abdomen master
Arterial blood drawing, aseptic separation serum, through 56 DEG C, 30 minutes inactivation treatment, the degerming rear subpackage of membrane filtration, put-20 DEG C of refrigerators and protect
Deposit standby.
1.2 Cell culture invitro
" cancer therapy drug research and experiment technology " is edited with reference to Han Rui.High-transfer human giant cell carcinoma of lung cell line PG cell strain
2×105/ ml is inoculated in containing 10% calf serum and the penicillin of 1%, streptomycin RPMI1640 culture fluid, and 37 DEG C, 5% is saturated
Cultivating under humidity, cell attachment grows, and the next day passes on once, cultivates 24 hours to the vigorous rear addition variable concentrations of cell growth
Normal mouse serum, this medicament composing prescription Contained Serum, CTX test.
1.3 observation items:
1. the impact on chick chorioallantoic membrane (CAM) angiogenesis: the method introduced with reference to Peter etc. is improved slightly, is solving
Cut open the branching-point quantity of counted under microscope chorioallantoic membrane blood vessel.The branching-point that vascular index=drug treating is crossed/untreated
Branching-point.
2. microplate reader is used to detect this medicament composing prescription Vitro Cytotoxicity to PG cell strain by MTT reducing process;
3. flow cytometer, laser confocal microscope, enzyme linked immunosorbent assay detection medicine it are respectively adopted to PG cell
The impact of strain cytokine vegf expression;
4. use flow cytomery medicine to PG cell strain bFGF, MMP-9, P53 gene, nm23 gene, cell week
Phase and apoptosis-induced impact.
2 animal experiment in vivo
2.1 method for building animal model
Lewis lung cancer transplanted tumor and the foundation of spontaneous Blood route metastasis model: take Lewis lung cancer cells suspension
(concentration is 1 × 10 to 0.2ml7/ ml) it is inoculated in inbred line C57The right axillary fossa of BL/6 mice is subcutaneous, within 14th, observes Local tumor growth
Situation.Operation group: Lweis lung cancer tumor cell suspension inoculation is in C57At BL/6 mice right lower extremity leg muscle, the 6th day, at tumor body
Upside sterile working excision band tumor limbs, the 21st day observe Lung metastases situation,.
H22Hepatocarcinoma (ascitic type) transplanted tumor and experimental blood road, the foundation of lymphatic metastasis model: take mice H22Hepatocarcinoma is thin
Born of the same parents suspension 0.2ml (2 × 106Individual) to be inoculated in the right axillary fossa of Kunming mouse subcutaneous.Observe H22During hepatocarcinoma experimental lung metastasis, mice
Tail vein injection 0.2ml (2 × 106Individual) oncocyte.Lymphatic metastasis model: take tumor cell suspension 0.05ml (concentration is 1 ×
108/ ml, containing oncocyte number 5 × 106Individual), it is inoculated in inbred line Kunming mouse left hind sole subcutaneous.
2.2 packets and treatment
Divide five groups of 1. NS groups: gavage normal saline 2. this medicament composing prescription small dose group: this medicament composing prescription is by 40g/kg body weight
Gavage 3. this medicament composing prescription heavy dose group every day: this medicament composing prescription gavages 4. CTX group by 60g/kg body weight every day: CTX is by 30mg/
Lumbar injection × 6 5. this medicament composing prescription low dose+CTX group next day of Kg body weight: usage is ibid.
2.3 observation item
Observe medicine to Lewis lung cancer mice, H22The growth of liver cancer mouse subcutaneous transplantation tumor, blood road and lymphatic metastasis, swollen
Tumor microvessel density (MVD) and vascular endothelial cell growth factor (VEGF) expression (ImmunohistochemistryMethods Methods), immune organ
The impact of protective effect etc..
(2) clinical research
1 case inclusive criteria
(1) this research selects pulmonary carcinoma, human primary gastrointestinal cancers, patient with breast cancer to be the object of observation;(2) have pathology, cytology examines
Disconnected foundation and the clear and definite person of histological classification;(3) clinical stages II~III phase person (UICC world TNM staging scale), and it is hands
Postoperative patient (being main person with row radical correction);(4) in 3 months after operation, and the therapist such as non-row radiotherapy, chemotherapy and BRM;(5) nothing
Metastasis and recurrence sign person;(6) Ka Shi (Karnofaky) scoring[23]Person more than 60 points;(7) without the serious heart, liver,
Organic or the functional illness such as brain, kidney and hemopoietic function of bone marrow obstacle person.
Exclusion standard is: (1) does not meets above-mentioned inclusion criteria person;(2) it is unwilling to participate in clinical trial person.
All cases totally 95 example, the maleest 42 examples, female 53 example, the oldest 67 years old, minimum 35 years old, the mean age 57.63
Year, wherein less than 40 years old person 14 example, 40~60 years old person 59 example, more than 60 years old person 22 example.Pulmonary carcinoma 33 example, human primary gastrointestinal cancers 28 example, mammary gland
Cancer 34 example,.
2 group technologies
It is divided into nonsmall-cell lung cancer (NSCLC), human primary gastrointestinal cancers, breast carcinoma (ABC) 3 groups, after planting packet by disease by project
It is respectively divided into matched group (alone chemotherapy) and observation group's (this medicament composing prescription adds chemotherapy) again with random method (random table method).
3 Therapeutic Method
(1) matched group (chemotherapy): chemotherapy regimen:
Nonsmall-cell lung cancer group: by CAP or NP scheme;Every 4 weeks is a cycle, totally 3~6 cycle.
Human primary gastrointestinal cancers group: by DLF or ELF or HDLF scheme;Every 4 weeks is a cycle, totally 3~6 cycle.
Breast carcinoma CMF or CAF scheme: every 4 weeks is a cycle, continuously 6 cycles for the treatment of
(2) observation group's (medicament composing prescription of the present invention adds chemotherapy): medicament composing prescription of the present invention is added by Shandong Prov. Hospital Drug Manufacturing Room
Work produces, and often wraps 9g (being equivalent to crude drug 80g).Patient per takes 1 bag, day 3 times, is monthly a course for the treatment of.Coordinate matched group simultaneously
Scheme chemotherapy.Take at least three course for the treatment of continuously.
4 observation index
Within 4.1 1, two years, metastasis, recurrence are observed.
Each position situation is checked, respectively according to clinical symptoms, sign, the inspection of lump Puncture cytology and image analysis etc.
Observe treatment and metastasis positions such as () lung, liver, brain, bone, adrenal gland, kidney, pericardium, subcutaneous tissue and in situ occurs in 1,2 years
Recurrence.
4.2 1, biennial rate of depositing is observed.
4.3 short term effects are observed.
After treating 3 months, observe VEGF in treatment Life For The Residents of Three Gorges Reservoir Before (K, S mark), body weight, cardinal symptom, peripheral blood
The change of the indexs such as content, immune indexes, Hemorheology.
4.4 untoward reaction are observed
Peripheral blood leucocyte, erythrocyte, hemoglobin, platelet and Liver and kidney function, ECG Change before and after detection treatment
Situation, toxicity evaluation is carried out with reference to the performance of WHO (1979) cancer therapy drug acute and subacute toxicity and indexing standard
Evaluation.
5. statistical method
All experiments and clinical data all input computer, use SPSS8.0 statistical package to set up data base also
Carry out statistical analysis, predominantly t inspection, x2Inspection, Ridit analysis, variance analysis.
Three, result of study
(1) basic research
1 experiment in vitro (Sero-pharmacological experiment)
The experiment of 1.1 pairs of chick chorioallantoic membrane (CAM) angiogenesis
Matched group CAM vascularity is uniform, and, disruption tortuous without blood vessel, medicament composing prescription Contained Serum group of the present invention can
Seeing that avascular area, circular chick chorioallantoic membrane produce blood vessel avoidance zone, angiogenesis significantly reduces.Statistical result showed under mirror:
Matched group, normal mouse serum group, low medicine group, high medicine group CAM vascular index are respectively 85.78 ± 10, and 82.55 ± 12.17,
44.29 ± 8.52,30.93 ± 7.35, CAM angiogenic growth is all had substantially by this medicament composing prescription Contained Serum low medicine group, high medicine group
Inhibitory action (P 0.01).
The impact on CAM angiogenesis of the table 1 medicament composing prescription of the present invention Contained Serum
Q detects note: with normal saline group ratio ▲ ▲ P 0.01
The observation of 1.2 pairs of PG cell toxic actions
This medicament composing prescription Contained Serum has obvious inhibiting effect to PG cell proliferation, and improves with medicine serum-concentration, acts on
Time lengthening inhibitory action strengthens
1.3 impacts that PG cell VEGE, bFGF, MMP-9 are expressed
Human lung carcinoma cell PG VEGF, bFGF, MMP-9 expression is higher, normal mouse serum to PG cell VEGE, bFGF,
MMP-9 expression has no significant effect, and this medicament composing prescription Contained Serum can significantly lower PG cell VEGE, bFGF, MMP-9 express
Level, and with medicine serum-concentration raise and extended durations of action, inhibitory action strengthen, chemotherapy to PG cell VEGE, bFGF,
MMP-9 expression also has a notable downward effect, and chemotherapy and this medicament composing prescription share to suppression PG cell VEGE, bFGF,
The expression of MMP-9 has synergism.
The table 2 impact on the expression of people's giant cell carcinoma of lung cell line PG cell VEGE
Note: Q detects: with calf serum group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.05 * * P 0.01
Each group of impact on the expression of bFGF of table 3
Q detects note: with matched group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.05 * * P 0.01
Each group of impact on the expression of MMP-9 of table 4
Q detects note: with matched group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.05 * * P 0.01
1.4 on PG cell P53 gene, the impact of nm23 gene expression
Human lung carcinoma cell PG P53 gene expression dose is higher, and nm23 gene expression dose is relatively low.Normal mouse serum is thin to PG
Born of the same parents' P53 Genes nm23 gene expression dose has no significant effect.This medicament composing prescription Contained Serum can significantly lower PG cell P53 gene
Expression, the notable nm23 gene expression dose that raises, and act on increasing with the rising of medicine serum-concentration and the prolongation of action time
By force, chemotherapy also has certain effect, and chemotherapy and this medicament composing prescription share and have synergism.
The impact that P53 is expressed by each group of table 5
Q detects note: with matched group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.05 * * P 0.01
Each group of impact on nm23 gene expression of table 6
Q detects note: with matched group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.05 * * P 0.01
1.5 may act on tumor cell G to induction apoptotic this medicament composing prescription Contained Serum that affects of PG1/ S node,
Tumor cell is made to block in G0-G1Phase, and stop tumor cell malignant proliferation, its apoptosis-induced effect by starting Apoptosis mechanism
Strengthen with the increase of medicine serum-concentration and the prolongation of action time.
This medicament composing prescription Contained Serum impact on PG cell cycle of table 7
2 animal experiment in vivo
2.1 impacts on local tumor
H22Hepatocarcinoma, Lewis lung cancer each treatment group tumor weight average is substantially less than matched group, compares with matched group, is respectively provided with notable
Sex differernce (P 0.05~0.01).This medicament composing prescription and CTX have share notable synergistic effect.
Table 8 medicament composing prescription of the present invention is to Lewis lung cancer mice in vivo antitumor effect result
Q detects note: with normal saline group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.05
2.2 impacts that tumor microvessel density (MVD) is expressed
Each medication group H22Hepatocarcinoma, Lewis lung cancer mouse tumor and microvasculatures surface density value thereof are all substantially less than comparison
Group (P 0.01), with CTX group ratio, this medicament composing prescription heavy dose group, this medicament composing prescription low dose+CTX group MVD value is substantially less than
CTX group, (P 0.01).
Table 9 H22Hepatocarcinoma, Lewis lung cancer tumor tissues mean vascular density
Q detects note: with normal saline group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * * P 0.01
2.3 impacts on tumor vegf expression
Each medication group VEGF positive cell surface density value, average gray value are all substantially less than matched group (P 0.05, P
0.01), this medicament composing prescription heavy dose group, this medicament composing prescription low dose+CTX group is substantially less than CTX group, (P 0.05, P 0.01).
Table 10 H22 hepatocarcinoma, Lewis lung cancer tumor tissues vegf expression averaged areal density
Q detects note: with normal saline group ▲ ▲ P 0.01 and CTX group than * P 0.05 * * P 0.01
Table 11 H22 hepatocarcinoma, Lewis lung cancer tumor tissues vegf expression average gray
Q detects note: with normal saline group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.05 * * P 0.01
2.4 couples of Lewis lung cancer, H22The impact of hepatocarcinoma Blood route metastasis
Each medication group Lung metastases rate, Pulmonary metastasis focuses number, metastatic tumor growth index, primary tumor tumor weight average are less than matched group;Chinese mugwort
Little+CTX group Pulmonary metastasis focuses number, primary tumor weight are significantly less than CTX group (P 0.05);End big group, the little+CTX that ends group Lung metastases suppression
Rate, pulmonary metastases growth inhibition ratio are significantly better than CTX group.
This medicament composing prescription of table 12 is to H22The impact of liver cancer mouse experimental lung metastasis
Note: Q detects with normal saline group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.01
The impact that Lewis lung cancer mice spontaneous lung is shifted by this medicament composing prescription of table 13
Q detects note: with normal saline group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.05
2.5 couples of H22The impact of liver cancer mouse lymphatic metastasis
Each medication group is to H22Hepatocarcinoma palmula transplanting mouse lung, rate of lymph-node metastasis, metastasis (individual) number are below matched group;
Little+the CTX that ends group Pulmonary metastasis focuses number significantly less than CTX group (P 0.01), end big group, the little+CTX that ends group number of involved lymph node notable
Less than CTX group (P 0.01), and lung, metastasis of lymph substantially alleviate;
Table 14 medicament composing prescription of the present invention is to H22The impact of liver cancer mouse lymphatic metastasis model Lung metastases
Q detects note: with normal saline group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.01
Table 15 medicament composing prescription of the present invention is to H22The impact of liver cancer mouse lymphatic metastasis model lymphatic metastasis
Q detects note: with normal saline group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.01
2.7 on Lewis lung cancer mice postoperative pulmonary, the impact of lymphatic metastasis
Each medication group is below matched group to the Mice Bearing Lewis Lung Cancer postoperative pulmonary rate of transform, Pulmonary metastasis focuses number, metastasis degree;
Little+the CTX that ends group Pulmonary metastasis focuses number is substantially less than CTX group (P < 0.05);Lymphatic metastasis situation: the taken lymph tying-in tissue of each group
Pathology serial section is observed and is had no lymphatic metastasis.
The impact that Mice Bearing Lewis Lung Cancer postoperative pulmonary is shifted by table 16 medicament composing prescription of the present invention
Q detects note: with normal saline group ratio ▲ P 0.05 ▲ ▲ P 0.01 and CTX group than * P 0.05
2.8 impacts on mouse immune organ
This medicament composing prescription can increase tumor-bearing mice thymus index, index and spleen index, increases bright with this medicament composing prescription group low dose of
Aobvious (P < 0.05);CTX group can significantly reduce thymus index, index and spleen index (P < 0.05~0.01);This medicament composing prescription low dose of with
CTX share, and tumor-bearing mice thymus, spleen atrophy caused by CTX can be had certain antagonism.
(2) clinical research
1. on tumor post-operation patient transfer in 1,2 years and the impact of recurrence
1,2 years transfer and relapse rates of pulmonary carcinoma observation group are respectively 10.00%, 25.00%, substantially less than matched group
38.46%, 61.54% (P all < 0.01);1,2 years transfer and relapse rates of total inspection group are respectively 6.67%, 16.67%, the lowest
28.57%, 48.57% (P < 0.05~0.01) in total matched group;This medicament composing prescription is pointed out to have significant metastasis, anti-recurrence
Effect.
Table 17 medicament composing prescription of the present invention is on tumor post-operation patient transfer and the impact of recurrence
Note: compare ▲ P 0.05 ▲ ▲ P 0.01 (P value is calculated by " the definite probabilistic method of four fold table data ") with matched group
2. 1,2 years survival rates of couple tumor post-operation patient compare
Observation group one, the biennial rate of depositing are respectively 93.33%, 86.67%, be significantly higher than matched group 74.29%,
54.29% (P 0.05, P 0.01).Point out this medicament composing prescription combined with chemotherapy can significantly improve the survival rate of tumor post-operation patient.
Tumor postoperative patient survival rate is compared by table 18 medicament composing prescription of the present invention
Note: compare ▲ P 0.05 ▲ ▲ P 0.01 (P value is calculated by " the definite probabilistic method of four fold table data ") with matched group
3. change (k.s) scoring for the treatment of Life For The Residents of Three Gorges Reservoir Before
Quality of life improves, stable, reduce observation group and be respectively 45.00%, 36.67%, 18.33%, matched group is respectively
It is 28.57%, 28.57%, 42.86%.Significant difference (P 0.05) is had between two groups
Life For The Residents of Three Gorges Reservoir Before change treated by table 19
Note: Ridit analyzes, U=2.3574 ▲ P 0.05 RObserve=0.5429 RComparison=0.6781
4. the change of body weight before and after treatment
Observation group rises, stable, reduction respectively 55.00%, 33.33%, 11.67%, and matched group is respectively
25.71%, 34.29%, 40.00%, there is significant difference (P 0.05) between two groups
The change of body weight before and after table 20 treatment
Note: Ridit analyzes, U=2.1857 P 0.05 RObserve=0.5681 RComparison=0.7041
5. clinical primary symptom change before and after treatment
Observation group improves, stablizes, increases the weight of respectively 54.29%, 31.43%, 14.29%, and matched group is respectively
28.00%, 30.00%, 42.00%, there is significant difference (P 0.05) between two groups
Before and after table 21 treatment, the change of clinical primary symptom is compared
Note: Ridit analyzes, U=1.8781 P 0.05 RObserve=0.5681 RComparison=0.7041
6. the change of VEGF content in peripheral blood before and after treatment
Treatment Hou Ge observation group reduces before the most relatively treating with VEGF content in matched group peripheral blood.Wherein pulmonary carcinoma observation group controls
After treatment, 23.87 ± 12.82pg/ml relatively treats front 31.59 ± 11.59pg/ml and significantly reduces (P 0.05).
Before and after table 22 treatment in peripheral blood VEGF content change (pg/ml)
Note: t detection compares ▲ P 0.05 before treatment
7. the change of immunologic function before and after treatment
CD before two groups of treatments3、CD4、CD4/CD8The most in various degree less than normal value, but two groups of no significant difference (P
0.05).Observation group CD after treatment3、CD4、CD4/CD8Relatively before treatment the most significantly raised (P 0.05), matched group CD3、CD4、CD4/
CD8Relatively treat the decline (P 0.05) that takes a step forward.Prompting chemotherapy has the side effect suppressing Cellular Immunologic Function In Patients further, and
This medicament composing prescription can alleviate the chemotherapy damage to Immune Function.
The change of immune indexes before and after table 23 treatment
Note: t detection compares ▲ P 0.05 before treatment
8. the change of hemorheology index before and after treatment
Before treatment, observation group and matched group lectin from hemolymph index are in the higher range of normal value or mostly beyond normal, treatment
Rear observation group indices (in addition to deformable index) significantly reduces before the most relatively treating (P 0.05~0.01), and matched group
Plasma viscosity, whole blood viscosity, blood reduced viscosity, ESR equation K value, erythrocyte aggregation index, Fibrinogen are the most relatively treated
Before significantly increase (P 0.05~0.01).
Hemorheological change before and after table 24 treatment
Note: t detection compares ▲ P 0.05 ▲ ▲ P 0.01 before treatment
9. untoward reaction is observed
Two groups all have leukocyte in various degree, hemoglobin, platelet to decline, periphery after observation group's relatively treatment of control group
Blood WBC, HGB, PLT decline mild degree, and number of cases is few, and matched group WBC reduces substantially, compares for two groups and has significant difference (P
0.05), no significant difference (P 0.05) between HGB, PLT two groups.Two groups of hearts, Liver and kidney function damage relatively light, based on I grade of infringement,
No significant difference (P 0.05) between two groups.
25 liang of table group toxicity compares
Four, research conclusion
" weakened body resistance blood stasis, evil poison multiple abscess, obstruction of collateral caused by windphlegm " is the pathogenic characteristic of tumor-blood-vessel growth and transfer, " " Fuzheng Huoxue,
Detoxicating and resolving stagnation of pathogens, calming wind and dredging collateral " for suppressing tumor-blood-vessel growth and the therapeutic rules of metastasis.This medicament composing prescription has and significantly presses down
Tumor-blood-vessel growth processed and metastasis recurrence effect, and notable prolongation tumor post-operation survival of patients phase, quality of making the life better, alleviate
Chemical therapy toxic side effect.It acts through minimizing tumor and interstitial MVD thereof, suppression promote tumor angiogenesis factor VEGF, BFGF,
The expression of MMP-9, lowers the expression of Mutation P53 gene protein, improves anti-metastasis gene NM23 gene expression, improves
Body height is viscous, hypercoagulability, protects body immune system, improves that cellular immune function etc. is multi-level, the combining of too many levels, Mutiple Targets
Conjunction mechanism realizes.
Attached clinical case:
(1) pulmonary carcinoma example: Lee xx, female, 65 years old.
First visit: cough, expectoration, right chest pain 6 months, breast CT is shown: the most vertical phrenic lymph nodes transfer of right lung cancer, postoperative pathological
Show: right lung adenocarcinoma, low-middle differentiation.The postoperative pemetrexed of row+cisplatin chemotherapy four cycle.More than 20 skies after existing chemotherapy, tell light
Degree cough, few expectorant, without chest pain, weak, asthma sometimes is felt oppressed, poor appetite, and two is just normal, and dormancy can.Previously body is good for.
Hope and hear palpation: typically can, god's clear language profit, lusterless complexion.Superficial lymph is tied not and substantially enlargement, the heart (-), right lung
Respiratory murmur is lower slightly, rale (-), liver spleen (-).The body of the tongue stasis of blood is dark, yellow fur, stringy and hesitant pulse.
Chinese medical discrimination: insufficiency of lung-QI, qi depression to blood stasis, knot in ecchymosis.
Western medicine diagnose: after right lung cancer mediastinal lymph node metastasis postoperative chemotherapy.
Method for the treatment of: " Fuzheng Huoxue, blood stasis-eliminating and stagnation-dissipating, detoxicating and fighting cancer;
Radix Astragali 45g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Rhizoma Atractylodis Macrocephalae 10g, Poria 15g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis
30g, Herba Scutellariae Barbatae 13g, Rhizoma Curcumae 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Fructus Psoraleae 30g,
Radix Glycyrrhizae Preparata 6g.Be decocted in water for oral dose, every day potion.
Examine again: cough still weighs, time cough white expectorant, food sleep two just can, yellow fur, thready pulse stringy and rapid pulse.
Upper prescription is drunk and is added: Bulbus Fritillariae Uninbracteatae 15g, Radix Platycodonis 10g, Fructus Trichosanthis 30g.
Repeatedly further consultation: based on Traditional Chinese Medicine Anti oncotherapy, foster lung QI invigorating, heat-clearing and toxic substances removing, dissipating phlegm and resolving masses are method, and main formula is such as
Under: Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, Rhizoma Curcumae 30g,
Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Platycodonis 10g, Semen Armeniacae Amarum 10g Radix Glycyrrhizae Preparata 6g, be decocted in water for oral dose, day
1 dose.
Plus-minus: rush of panting less, dry cough, adds Radix Panacis Quinquefolii 3g, Radix Asteris 15g, Radix Adenophorae (Radix Glehniae) 20g;Cough expectorant is yellow, and red tongue rolling pulse adds gold
Semen Fagopyri Esculenti 15g, Arisaema Cum Bile 10g, Radix Peucedani 10g;Weakness due to chronic disease is unable, adds Fructus Lycii 15g, Rhizoma Atractylodis Macrocephalae 20g, seed of Job's tears 30g.
Adhere to taking medicine nearly more than 3 years, add and subtract according to above symptom, periodic review tumor presence, stable disease, have no that tumor is multiple
Send out and metastasis.Patient's ordinary circumstance is good, and diet two is just normal, and life is normal.
(2) pulmonary carcinoma example: Zheng xx, man, 66 years old.
First visit: patient is medical because of " paroxysmal zest dry cough May more than, increase the weight of January ", looks into breast CT and shows: upper right pulmonary carcinoma,
Mediastinal lymph node metastasis, patient disagrees operation, because of this journey Gamma knife treatment, totally 13 times, weight loss during Gamma knife treatment
5kg, checks further and finds right Kidney neoplasms, neoplasm metastasis not except.First visit disease is seen: cough, based on dry cough, without obvious breast
Vexed, chest pain, red tongue, thick, yellow and greasy fur.Examining it is: lump in the right hypochondrium, lung yin virtual loss, ecchymosis internal resistance.Patient's elderly men, old,
Deficiency of both QI and YIN, lung yin virtual loss then cannot go up honor, causes cough, based on dry cough, red tongue;Taking a broad view of the four diagnostic methods, patient demonstrate,proves genus lung yin and loses
Void, the card of ecchymosis internal resistance.
Method for the treatment of: nourishing lung yin, dissolving blood stasis and detoxication prescription: Radix Adenophorae (Radix Glehniae) 10g, Radix Ophiopogonis 10g, Fructus Schisandrae Chinensis 10g, Bulbus Lilii 30g, Bulbus Fritillariae Uninbracteatae 15g,
Semen Armeniacae Amarum 15g, Radix Scutellariae 9g, Herba Agrimoniae 18g, Semen Ziziphi Spinosae 30g, Caulis Polygoni Multiflori 30g, Rhizoma Curcumae 30g, Herba Scutellariae Barbatae 30g, Radix Salviae Miltiorrhizae 10g, Colla Corii Asini 15g,
The each 15g of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), is decocted in water for oral dose, day 1 dose.
Further consultation: take medicine 14 doses, cough takes a turn for the better earlier above, no more side effects, it is contemplated that after patient's Gamma knife treatment, hemogram is relatively low,
Therefore treatment by Chinese herbs side is still with front as the end, adds and subtracts in right amount, to improve symptom.Prescription: Radix Adenophorae (Radix Glehniae) 10g, Radix Ophiopogonis 10g, Fructus Schisandrae Chinensis
10g, Bulbus Lilii 30g, Bulbus Fritillariae Uninbracteatae 15g, Endothelium Corneum Gigeriae Galli 30g, each 15g of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Herba Patriniae 30g, Semen Ziziphi Spinosae 30g, Caulis Polygoni Multiflori 30g, Herba Solani Nigri
30g, Radix Salviae Miltiorrhizae 10g, Fructus Jujubae 7 pieces, Colla Corii Asini 15g, Radix Scutellariae 9g, it is decocted in water for oral dose, day 1 dose.
Repeatedly further consultation: first to treat radiotherapy side effect, be arranged above main plus-minus.After based on Traditional Chinese Medicine Anti oncotherapy,
" Fuzheng Huoxue, heat-clearing and toxic substances removing, dissipating phlegm and resolving masses are method, and main formula is as follows: Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, chicken
Endothelium corneum 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, Rhizoma Curcumae 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, hook
Rattan 10g, Radix Platycodonis 10g, Semen Armeniacae Amarum 10g Radix Glycyrrhizae Preparata 6g, be decocted in water for oral dose, day 1 dose.
Take the circumstances into consideration to add and subtract according to symptom variation: rush of panting less, dry cough, add Radix Panacis Quinquefolii 3g, Radix Asteris 15g, Radix Adenophorae (Radix Glehniae) 20g;Cough expectorant
Huang, red tongue rolling pulse, add Rhizoma Fagopyri Dibotryis 15g, Semen Coicis 30g, Radix Peucedani 10g;Tumor increases, and chest pain is coughed, and adds Eupolyphaga Seu Steleophaga 6g, Nidus Vespae
10g, Herba Salviae Chinensis 15g;Weakness due to chronic disease is unable, adds Rhizoma Atractylodis Macrocephalae 15g, Fructus Lycii 15g, Caulis Spatholobi 30g.
Coordinate Chinese patent medicine FUFANG BANMAO JIAONANG, Shenyi capsule, Jinlong capsule etc..
Adhering to taking medicine more than 6 years, add and subtract according to above symptom, check lung, Kidney neoplasms are change after radiotherapy, and tumor change is not clear
Aobvious.Patient's ordinary circumstance is good, and diet two is just normal, takes care of oneself, and band tumor is survived the most so far.
(3) pulmonary carcinoma example: king x, female, 55 years old.
First visit: patient's " cough sputum mixed with blood January ", right upper lung occupy-place seen from breast CT, row excision, pathology shows: right
Leaf small cell carcinoma on lung, swollen thing size 4.5 × 4 × 3cm, involve pleura, the bronchus broken ends of fractured bone is clean, lymph node: bronchus 0/3, leaf
Between 0/2, SABC: CD56 (+), Syn (+), ek focal (+), LCA (), post-operative recovery is fair, postoperative January begin be in hospital row
EP scheme chemotherapy: VP16 100mg × 5;DDP 40mg×3.Digestive tract side reaction III degree, bone marrow depression II degree, through Chinese and western drugs
Symptomatic treatment takes a turn for the better, and in 2 cycles after existing chemotherapy, cough occurs without obvious inducement, look into NSE18ng/ml before Yu Yizhou, and rabat shows: vertical
Every the streak shadow of upper right, prepare to continue chemotherapy.
Inscribing disease, cough, few expectorant, poor appetite, the few China of shallow complexion, dynamic then shortness of breath and fatigue, two just adjust.Red tongue with thin fur, thready pulse
Number.Examining it is: the postoperative deficiency of both QI and YIN of lump in the right hypochondrium, and waste heat is not to the greatest extent (small cell lung cancer).Patient's old women, has chronic lung disease medical history 20
Yu Nian, lung qi deficiency in origin, pathogen is taken advantage of a weak point, and is reluctant to leave with the passing of time, and blood stasis dispelling is reduced phlegm, and accumulates to hinder and forms lump in the right hypochondrium in lung, after postoperative and chemotherapy just
Gas is more hindered, and deficiency of vital energy blood deficiency then body loses supports, therefore primary disease is always deficiency of both QI and YIN, the card that residual poison is not most.Chemotherapy in Patients side reaction is heavier,
Therefore Chinese medicine is to alleviate chemotherapy side effect, and with benefiting QI and nourishing blood, nourishing the liver and kidney is method, adds and subtracts in right amount, the combination of Chinese and Western medicine, suits the medicine to the illness
Process.
Prescription is as follows: Rhizoma Coptidis 6g, Radix Aucklandiae 10g, Radix Codonopsis 20g, Rhizoma Atractylodis Macrocephalae 15g, Poria 15g, Radix Glycyrrhizae 10g, Flos Inulae 10g, generation
Haematitum 10g, Rhizoma Zingiberis 6g.Caulis Bambusae In Taenia 20g.JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 45g.Radix Peucedani 10g, is decocted in water for oral dose by 7 doses, day 1 dose.
Further consultation: taking medicine 7 doses, symptom take a favorable turn, it is contemplated that patient's hemogram is relatively low, and therefore Chinese medicine changes benefiting QI and nourishing blood into, nourishing
Liver and kidney is method.Prescription: Radix Astragali Preparata 40g, Radix Angelicae Sinensis 10g, Radix Codonopsis 20g, each 15g of Radix Asparagi and Radix Ophiopogonis, Rhizoma Polygonati 20g, Caulis Spatholobi 30g, Rhizoma Fagopyri Dibotryis
10g, Endothelium corneum 15g, each 15g of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Fructus Lycii 15g, Semen Cuscutae 15g, Fructus Ligustri Lucidi 15g, Caulis Bambusae In Taenia 20g, Herba Hedyotidis Diffusae 20g, crow gallbladder
Sub-6g, is decocted in water for oral dose by 7 doses, day 1 dose.
Repeatedly further consultation: patient makes a definite diagnosis pulmonary carcinoma the nearlyest 6 years, the first half, chemotherapy was main, coordinates Chinese medicine, relatively smoothly completes the course for the treatment of,
Tumor is controlled.Within nearly 5 years, adhere to that treatment by Chinese herbs is main, dialectical decoction and antineoplastic Chinese traditional medicine fit applications.Traditional Chinese Medicine Anti tumor
Treatment is with " Fuzheng Huoxue, heat-clearing and toxic substances removing, dissipating phlegm and resolving masses as method, and main formula is as follows: Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae
10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, Rhizoma Curcumae 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis
10g, Ramulus Uncariae Cum Uncis 10g, Radix Platycodonis 10g, Semen Armeniacae Amarum 10g Radix Glycyrrhizae Preparata 6g, be decocted in water for oral dose, day 1 dose.
Take the circumstances into consideration to add and subtract according to symptom variation: rush of panting less, dry cough, add Bulbus Lilii 20g, the Rhizoma Atractylodis Macrocephalae 10, Radix Asteris 15g, Radix Adenophorae (Radix Glehniae)
20g;Cough expectorant is yellow, and red tongue rolling pulse adds Rhizoma Fagopyri Dibotryis 15g, Bulbus Fritillariae Thunbergii 10g, Radix Peucedani 10g;Tumor increases, and chest pain is coughed, and adds Herba Selaginellae
10g, Eupolyphaga Seu Steleophaga 6g, Nidus Vespae 10g, Herba Salviae Chinensis 15g;Weakness due to chronic disease is unable, adds Fructus Lycii 15g, Semen Coicis 30g, Caulis Spatholobi
30g。
Adhering to taking Chinese medicine more than 5 years so far always, add and subtract according to above symptom, often the check state of an illness is without recurrence and transfer,
Whole body ordinary circumstance is good, has recovered part work, and quality of life is preferable.
(4) breast carcinoma, Liu xx, female, 60 years old.
First visit: during health check-up, breast examination touches left swelling of the breast thing, mobility can, with surrounding tissue without obvious adhesion, row mammary gland
Tumor resection art, pathology prompting infiltration ductal carcinomas of breast, then at general anesthesia descending left breast cancer radical correction, postoperative pathological shows (left)
Infiltration ductal carcinomas of breast, axillary gland (-), ER (-), PR (-).Postoperative row conventional chemotherapy, chemotherapy regimen is TC.
Inscribe patient diet can, defecation is normal, dormancy can, this is old women, and body constitution virtual loss is the most old, Post operation,
After chemotherapy 2 months at present, belong to the card of phlegm and blood stasis.Examine it: red tongue, have indentation, white and thin fur, weak pulse.Method for the treatment of: reducing phlegm and fever, solves
Poison eliminating stagnation.Prescription is as follows: Radix Rehmanniae 15g, Fructus Corni 15g, Caulis Spatholobi 20g, Herba Epimedii 15g, Radix Astragali 20g, Herba Agrimoniae 20g, the Rhizoma Anemarrhenae
10g, Radix Curcumae 10g, Herba Taraxaci 20g, Nidus Vespae 10g, Radix Polygoni Multiflori 20g, Pseudobulbus Cremastrae Seu Pleiones 10g, Herba Scutellariae Barbatae 20g, Fructus Lycii 15g, be decocted in water for oral dose,
Day 1 dose.
Further consultation: after taking medicine, private prosecution is the most slightly better, muscle power has increasing, no more side effects, and side's medicine slightly increases and decreases, and goes Herba Agrimoniae, summer
Hay, adds by Radix Sophorae Flavescentis, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), strengthens antitumor action, need Gu to protect patient's gastric qi simultaneously.
Taking Chinese medicine during chemotherapy, top is added and subtracted, and side reaction is inconspicuous, and chemotherapy smoothly completes always.Chinese medicine spleen invigorating soothing liver-QI,
Heat-clearing and toxic substances removing, blood stasis-eliminating and stagnation-dissipating are method, and prescription is as follows: Radix Codonopsis 30g, Rhizoma Atractylodis Macrocephalae 10g, Poria 15g, Semen Coicis 20g, Radix Bupleuri 10g, Radix Scutellariae
10g, Herba Salviae Chinensis 15g, Fructus Akebiae 15g, Herba Scutellariae Barbatae 20g, Pseudobulbus Cremastrae Seu Pleiones 10g, Radix Ranunculi Ternati 10g, Carapax Trionycis (processed) 15g, dry maxima skin 9g, Rhizoma Curcumae
15g, each 15g of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), be decocted in water for oral dose, day 1 dose.
Repeatedly further consultation: after chemotherapy completes, long-term treatment by Chinese herbs is main, with " Fuzheng Huoxue, heat-clearing and toxic substances removing, dissipating phlegm and resolving masses is
Method, main formula is as follows: Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae
13g, Rhizoma Curcumae 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Bupleuri 10g, Radix Curcumae 10g, Rhizoma Cyperi
10g, Radix Angelicae Dahuricae 10g, Rhizoma Chuanxiong 10g, Radix Glycyrrhizae Preparata 6g, be decocted in water for oral dose, day 1 dose.
Plus-minus is taken the circumstances into consideration: the most tired according to symptom variation, indigestion and loss of appetite lack of appetite, loose stool, add Radix Pseudostellariae 15g, Rhizoma Atractylodis Macrocephalae 20g, Rhizoma Dioscoreae
30g;Being irritable and getting angry easily, sleeps poor, worries too much, and adds Fructus Gardeniae 10g, Caulis Polygoni Multiflori 20g, Cortex Albiziae 20g;Take the circumstances into consideration nourishing the liver and kidney, add Fructus Lycii
15g, Fructus Ligustri Lucidi 15g, Semen Cuscutae 15g.
Coordinate Chinese patent medicine XIHUANG WAN, FUFANG BANMAO JIAONANG, Shenyi capsule etc..
Adhering to taking medicine more than 6 years, add and subtract according to above symptom, repeatedly check has no obvious relapse and metastasis sign, and patient is general
All right, diet two is just normal, and stable disease is for many years.
(5) breast carcinoma: yellow ××, female, 59 years old.
First visit: be not intended to find more than left swelling of the breast thing April, crater nipple, gradually to grow up, first visit is breast carcinoma, row left breast cancer
Radical correction, postoperative pathological " infiltration ductal carcinomas of breast, axillary lymph carry down shifting 3/12 ", surgery recovery is good, postoperative row chemotherapy one
Journey, medicinal TP scheme chemotherapy.Existing the most in high spirits, diet two is just normal, dormancy can, but nocturia frequency, without dysurea.Dimly red tongue, thin fur, arteries and veins
Heavy thin.Chinese medical discrimination: residual poison is not clear, spleen kidney deficiency.Legislation: eliminating toxic substances to remove stasis, tonifying speen and tonifying kidney, prescription is as follows: Herba Taraxaci 20g, yellow
A kind of reed mentioned in ancient books 9g, Pseudobulbus cremastrae seu pleiones 9g, Rhizoma Bolbostematis 15g, Rhizoma Curcumae 9g, Herba Scutellariae Barbatae 30g, Caulis Spatholobi 30g, Pericarpium Citri Reticulatae 9g, Rhizoma Atractylodis Macrocephalae 9g, Poria 9g, the Radix Aucklandiae
9g, each 9g of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Fructus Alpiniae Oxyphyllae 9g, Fructus Lycii 15g, be decocted in water for oral dose, every day potion.
Examine again: during chemotherapy, add and subtract with disease.Sleep poor, vexed, yellow and thin fur, deep-thready pulse.Top adds Fructus Gardeniae (parched) 9g, Semen Ziziphi Spinosae
20g;Frequent micturition, adds Semen Plantaginis 15g seed of Job's tears 30g.
Further consultation: sleep takes a turn for the better, urine frequency takes a turn for the better, and left upper extremity is ached sometimes, thin fur, deep-thready pulse.The party is as follows: Herba Taraxaci
20g, Caulis Spatholobi 30g, fry Pericarpium Citri Reticulatae 9g, Rhizoma Atractylodis Macrocephalae 9g, Poria 9g, each 15g of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Ramulus Cinnamomi 9g, Caulis Piperis Kadsurae 30g, Retinervus Luffae Fructus 9g, female
Loyal sub-15g, Pseudobulbus cremastrae seu pleiones 9g, Herba Scutellariae Barbatae 30g, be decocted in water for oral dose, every day potion.
Repeatedly further consultation: chemotherapy smoothly completes, long-term treatment by Chinese herbs is main afterwards, Chinese medicine method plan benefiting QI and nourishing blood, invigorating the spleen and regulating the stomach,
Eliminating toxic substances to remove stasis is main, and main formula is as follows: Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis
30g, Herba Scutellariae Barbatae 13g, Rhizoma Curcumae 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Bupleuri 10g, strongly fragrant
Gold 10g, Rhizoma Cyperi 10g, Radix Angelicae Dahuricae 10g, Rhizoma Chuanxiong 10g, Radix Glycyrrhizae Preparata 6g, be decocted in water for oral dose, day 1 dose.
Plus-minus is taken the circumstances into consideration: the most tired according to symptom variation, indigestion and loss of appetite lack of appetite, add Radix Pseudostellariae 15g, Rhizoma Atractylodis Macrocephalae 20g, lumbar and back pain adds osmanthus
Branch 5g, Caulis Piperis Kadsurae 20g, Cortex Eucommiae 15g;Being irritable and getting angry easily, sleeps poor, worries too much, and adds Caulis Polygoni Multiflori 20g, Cortex Albiziae 20g;Take the circumstances into consideration nourishing the liver and kidney,
Add Radix Angelicae Sinensis 10g, Fructus Lycii 15g.
Tamoxifen 10mg Bid is coordinated to take 5 years.
Adhering to taking traditional Chinese medicine more than 6 years, add and subtract according to above symptom, repeatedly check has no obvious relapse and metastasis sign, patient
Ordinary circumstance is good, and diet two is just normal, and stable disease for many years, has no that tumor recurrence shifts.
(6) human primary gastrointestinal cancers: road, female, 55 years old.
First visit: patient often occurred abdominal distention before 1 year, stomachache, based on epigastrium dull pain, and time have singultus, do not give
To pay special attention to, rear patient gradually occurs that epigastrium pain increases the weight of, and epigastrium can touch hard lump, and row gastroscopy of being admitted to hospital is pointed out
Gastric cancer, row total gastrectomy, postoperative pathological points out: poorly differentiated adenocarcinoma cancer, penetrates muscle layer and reaches placenta percreta, lymphatic metastasis 11/22,
Post-operative recovery can, postoperative January row systemic chemotherapy, oxaliplatin, xeloda chemotherapy 2 cycle.
Existing conscious inappetence, feed is few, and fatigue and weak examines it: shallow complexion is simple and unadorned, and red tongue with thin fur, sublingual vessel is light
Purple thick long, examine deep-thready pulse.Patient demonstrate,proves and always belongs to weakness of the spleen and stomach, method for the treatment of: invigorating the spleen and stomach, detoxicating and resolving stagnation of pathogens.Side intends Xiangsha Liujunzi decoction and adds
Subtract.Prescription is as follows: Radix Pseudostellariae 15g, Rhizoma Atractylodis Macrocephalae 10g, Poria 15g, Endothelium corneum 20g, Radix Aucklandiae (Radix Vladimiriae) 6g, Rhizoma Coptidis 6g, each 15g of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), raw
Semen Coicis 20g, Colla Corii Asini 10g, Arillus Longan 15g, Radix Angelicae Sinensis 10g, Fructus Lycii 15g, Carapax Trionycis 15g, Semen Cuscutae 15g, Caulis Spatholobi 30g, be decocted in water for oral dose,
Day 1 dose.
Further consultation: patient's muscle power takes a turn for the better earlier above, takes food the most, but soft stools, shapeless, desire for hot drinks, thin fur, thready and stringy pulse.
The most square as follows: Radix Pseudostellariae 15g, Rhizoma Atractylodis Macrocephalae 10g, Poria 10g, Pericarpium Citri Reticulatae 10g, Radix Aucklandiae (Radix Vladimiriae) 9g, each 15g of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Endothelium corneum 20g, raw Job's tears
Rice 30g, Fructus Jujubae 2 pieces, Caulis Spatholobi 30g, Colla Corii Asini 15g, Pseudobulbus Cremastrae Seu Pleiones 10g, Cortex Albiziae 10g, Herba Scutellariae Barbatae 20g, Semen Myristicae 15g, it is decocted in water for oral dose,
Day 1 dose.
Patient continues 10 cycles of chemotherapy, coordinates and takes above Chinese medicine plus-minus, and process is smooth, is the most just adjusting diet two
Often, without other chemotherapy side effects, general status is good.
Repeatedly further consultation: after chemotherapy, always based on Chinese medicine antineoplaston, is aided with Supporting Therapy to the ill, with spleen invigorating benefit
Gas, heat-clearing and toxic substances removing, dissipating phlegm and resolving masses are method, and main formula is as follows: Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli
15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, Rhizoma Curcumae 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis
10g, Radix Sanguisorbae 15g, Herba Patriniae 15g, Caulis Sargentodoxae 10g, Radix Glycyrrhizae Preparata 6g are decocted in water for oral dose, day 1 dose.
Take the circumstances into consideration to add and subtract according to symptom variation: fatigue and weak, indigestion and loss of appetite lack of appetite, add Radix Codonopsis 20g, Rhizoma Atractylodis Macrocephalae 15g, Poria 20g, Semen Coicis
30g;Big loose stool is thin, or just frequency diarrhoea, adds Cortex Phellodendri 10g, Semen Euryales 20g, Rhizoma Dioscoreae 20g;Antitumor preventing tumor relapse and metastasis, adds Fructus actinidiae chinensis
Root 10g, Eupolyphaga Seu Steleophaga 9g, Nidus Vespae 10g, Herba Hedyotidis Diffusae 20g;Weakness due to chronic disease is unable, adds Radix Pseudostellariae 20g, Radix Angelicae Sinensis 10g, Fructus Lycii
15g。
Adhering to taking medicine for many years, add and subtract according to above symptom, periodic review tumor presence, patient belongs to Gerontal gastric cancer, postoperative 1 year
Relapse and metastasis, treatment by Chinese herbs is main, though the state of an illness is in slowly progress, but patient's ordinary circumstance is good, and diet two is the most normal, life
Basic self-care, band tumor were survived more than in February, 2.
(7) liver pancreas cancer example: Zhao xx, man, 54 years old.
First visit: more than right side side of body flank pain, dull pain half a year, without being clearly better after certainly taking tablet for alleviating pain, increase the weight of first quarter moon and go to a doctor, OK
Abdominal B type ultrasonography shows that right lobe of liver has a Space-occupying lesion, row biopsy prompting primary hepatocyte hepatocarcinoma, looks into abdominal CT further and shows right lobe of liver
Multiple Space-occupying lesion, rear 3 row interventional therapys, liver function transaminase disorder after intervention.Existing patient's pain in the hepatic region, diet sleep is poor,
Examine it: dimly red tongue yellow fur is thick, string of feeling the pulse.Examining it is: dampness and heat stasis liver and gall (hepatocellular carcinoma).This suffers from previously chronic hepatitis B
For many years, for many years, the irritability stasis of blood is stagnant for liver cirrhosis for history, causes liver and gall unfavorable, and dampness and heat stasis forms the liver rump, and patient's tongue is dark red, and yellow fur thickness is wet
Hot stasis blocking liver and gall as.Prescription is as follows: Radix Astragali 30g, Herba Artemisiae Scopariae 20g, Semen Coicis 20g, Herba Salviae Chinensis 15g, Fructus Akebiae 15g, half
Lotus 20g, Fructus Bruceae 6g, Flos Campsis 10g, Herba Duchesneae Indicae 15g, dry maxima skin 6g, Herba Hedyotidis Diffusae 20g, Radix Curcumae 15g, each 15g of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), Herba Pogostemonis
10g, Radix Scutellariae 10g, Fructus Lycii 15g, be decocted in water for oral dose, day 1 dose.
Further consultation: after taking medicine, subjective symptoms take a favorable turn earlier above, therefore no more side effects, serve on.
Repeatedly further consultation: because of abnormal liver function, fails to continue interventional therapy, always based on Chinese medicine antineoplaston, auxiliary
With Supporting Therapy to the ill, with invigorating the spleen and benefiting QI, Shugan Qingre, dissipating phlegm and resolving masses as method, main formula is as follows: Radix Astragali 60g, Fructus Ligustri Lucidi 30g, half
Summer 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, Rhizoma Curcumae 30g, Scorpio 10g, Spina Gleditsiae 15g, raw male
Oyster 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Bupleuri 10g, Fructus Aurantii 5g, Radix Paeoniae Alba 10g, Radix Glycyrrhizae Preparata 6g are decocted in water for oral dose, day 1 dose.
Take the circumstances into consideration to add and subtract according to symptom variation: fatigue and weak, indigestion and loss of appetite lack of appetite, add Radix Codonopsis 20g, Rhizoma Atractylodis Macrocephalae 15g, Poria 20g, Semen Coicis
30g;Big loose stool is thin, or just frequency diarrhoea, with Semen Euryales 20g, Rhizoma Dioscoreae 20g, Radix Paeoniae Alba 15g;Hepatalgia, coerces rib feeling of distension and oppression, easily flies into a rage,
Add Radix Curcumae 10g, Cortex Albiziae 20g, Radix Bupleuri (processed with vinegar) 10g.Antitumor preventing tumor relapse and metastasis, adds Fructus Akebiae 10g, Eupolyphaga Seu Steleophaga 9g, reveals honeybee
Room 10g, Herba Duchesneae Indicae 10g, Carapax Trionycis 15g;Ascites abdominal distention, adds Herba Solani Nigri 10g, Semen Plantaginis 20g, Pericarpium Arecae 15g;Jaundice yellowish body, yellowish urine, add
Herba Artemisiae Scopariae 20g, Rhizoma Polygoni Cuspidati 15g, Herba Patriniae 20g;Weakness due to chronic disease is unable, adds Semen Cuscutae 20g, Radix Angelicae Sinensis 10g, Fructus Lycii 15g.
Patient adheres to taking medicine more than 1 year, and band tumor is survived 1 year 4 months, adds and subtracts according to above symptom, the time of about 1 year
In, although for later period of hepatocarcinoma, symptom is more heavier, according to symptom to top appropriate adaptation after, life in patients can be improved,
Extend life cycle.Patient's ordinary circumstance still can, without serious painful symptom, quality of life is preferable.Ultimately succumb to liver failure.
(8) liver pancreas cancer example: poplar xx, female, 79 years old.
First visit: jaundice occur 1 week, companion's yellowish urine, just white, epigastrium pain, abdominal CT and B ultrasonic all point out head of pancreas occupy-place sexually transmitted disease (STD)
Becoming, size is 3.2 × 3.1cm, obscure boundary.In BJ Union Hospital's row exploratory laparotomy, art being shown in, swollen thing is positioned at Diseases In Pancreatic Head,
All there is adhesion with santorini's papilla portion, stomach, fail to excise, close abdomen.Taking definitive pathological diagnosis is pancreas adenocarcinoma.Postoperative persistence upper abdomen
Portion's pain, abdominal distention, epigastric fullness, postemphasis of taking food, more than ten jin of becoming thin, appetite is poor, skin yellow sclera, dark coloured urine, and stool is not smooth,
Red tongue, dry, rough and yellow fur, stringy pulse.Method for the treatment of: relieving distension and oppression, invigorating the spleen and regulating the stomach, heat clearing away jaundice eliminating.Intend zhishi xiaopi pills and close Herba Artemisiae Scopariae Decoctionization sanction.
Radix Codonopsis 20g, Fructus Aurantii Immaturus 10g, Poria 20g, Rhizoma Atractylodis Macrocephalae 15g, Rhizoma Zingiberis 10g, Cortex Magnoliae Officinalis 10g, Rhizoma Pinelliae 10g, Carapax Trionycis (processed) 10g, Rhizoma Curcumae 10g, tiger
Cane 10g, Herba Artemisiae Scopariae 20g, Fructus Gardeniae 10g, Herba Salviae Chinensis 15g, Endothelium corneum 10g, each 15g of JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata), be decocted in water for oral dose, every day potion.
Further consultation: after medicine, feed take a favorable turn, and relaxes suitable under the heart, and stomachache alleviates, and jaundice is slightly taken a favourable turn, red tongue, thin and whitish fur, stringy pulse.Abdomen
Pain is the lightest but still continuous has a pain.Top adds Radix Angelicae Sinensis 10g, Fructus Toosendan 10g.
Examining: pain substantially alleviates, two just adjust, and xanthochromia is the most inconspicuous again, check Abdominal B type ultrasonography show head of pancreas swell thing 3 ×
3cm.Add and subtract above following the service.Treating more than four months, stable disease, patients ' life quality is preferable.
Repeatedly further consultation: laparotomy exploration is postoperative does not does chemicotherapy, always based on Chinese medicine antineoplaston, is aided with and props up to the ill
Holding treatment, with invigorating the spleen and benefiting QI, Shugan Qingre, dissipating phlegm and resolving masses as method, main formula is as follows: Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, old
Skin 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, Rhizoma Curcumae 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Trionyx sinensis Wiegmann
First 10g, Ramulus Uncariae Cum Uncis 10g, Radix Sanguisorbae 15g, Herba Patriniae 15g, Caulis Sargentodoxae 10g, Radix Glycyrrhizae Preparata 6g are decocted in water for oral dose, day 1 dose.
Take the circumstances into consideration to add and subtract according to symptom variation: fatigue and weak, indigestion and loss of appetite lack of appetite, add Radix Codonopsis 20g, Rhizoma Atractylodis Macrocephalae 15g, Poria 20g, Semen Coicis
30g;Epigastrium pain, coerces rib feeling of distension and oppression, adds Radix Curcumae 10g, Rhizoma Corydalis 20g, Herba Solani Lyrati 10g, Pericarpium Arecae 20g;Antitumor preventing tumor recurs
Transfer, adds Fructus Akebiae 10g, Eupolyphaga Seu Steleophaga 9g, Nidus Vespae 10g, Herba Duchesneae Indicae 10g, Carapax Trionycis 15g;Ascites abdominal distention, adds Herba Solani Nigri 10g, Semen Plantaginis
20g, Pericarpium Arecae 15g;Jaundice yellowish body, yellowish urine, add Herba Artemisiae Scopariae 20g, Rhizoma Polygoni Cuspidati 15g, Herba Patriniae 20g;Weakness due to chronic disease is unable, adds Semen Cuscutae
20g, Radix Angelicae Sinensis 10g, Fructus Lycii 15g.
Patient cancer of pancreas late period, laparotomy exploration is postoperative does not does chemicotherapy, always based on Chinese medicine antineoplaston, according to
After symptom is to top appropriate adaptation, life in patients can be improved with mitigation symptoms, extend life cycle.Patient carries tumor to survive 1
Nian Yu, patient's ordinary circumstance still can, without serious painful symptom, life can be taken care of oneself, and quality of life is preferable.
Tumor is a systemic disease, and the concrete embodiment of neoplasm metastasis its generalization especially.Present inventors have proposed and turn
The pathogenesis hypothesis " weakened body resistance blood stasis is said " " expectorant poison multiple abscess is said " " obstruction of collateral caused by windphlegm is said " moved.The basic reason of its transfer is that healthy energy is lost
Void, accumulates in evil poison.Its pathogenesis develops in being then and accumulates evil poison, gas consumption blood trouble, does not the most press down heresy, and evil poison is taken advantage of a weak point in opponent's defence, and flees meridians, QI and blood,
Visitor, in internal organs, with the passing of time becomes long-pending.Its process fully demonstrates in causing a disease because of void, the most due to illness causes void, and positive exogenous pathogen is contained, and does not the most press down the pernicious of heresy
Development law.The present inventor is postoperative for cancer patient and after Radiotherapy chemotherapy, the pathogenesis of transfer and relapse also has novel viewpoint: 1. think
No matter perform the operation, after Radiotherapy chemotherapy, uncharm purpose though having reached effectively to subtract tumor, but fail fundamentally to release patient's internal organs, the moon
Sun, the imbalance of QI and blood function, void, poison, the stasis of blood, expectorant, knot run through its evolution process.Therefore, by after cancer patient's operation, Radiotherapy chemotherapy
Pathogenic characteristic can be attributed to " weakened body resistance blood stasis, residual poison are the most clear ";2. after operation, Radiotherapy chemotherapy, transfer is positive exogenous pathogen Sheng, heresy
Poison Gua opens, does not the most press down the result of heresy, can set forth one's views from " ailment said due to cold or exposure ", and wind holds expectorant, the stasis of blood under the arm, the most nowhere less than, or hinder in lung that (lung turns
Move), or strongly fragrant in liver (hepatic metastases), or move in kidney (kidney transfer), or flee meridians, then expectorant, the stasis of blood can and not all right, then deteriorated case clump
Raw.Opinion its " wind ", when duty in visceral dysfunction, negative and positive of qi and blood virtual loss, gradually give birth to wind syndrome caused by deficiency.Therefore, by transfer occur and
The pathogenic characteristic of evolution can be attributed to " stirring-up of pathogenic wind in the interior resulting from deficiency, phlegm stagnation in collateral (expectorant poison multiple abscess) ", and the former is the root of transfer and relapse,
The latter is the power of transfer and relapse, and the former is this, and the latter is mark.This is Mechanism Study phase to tumor invasion and metastasis with modern medicine
It coincide: empty--it is embodied in the immunosurveillance inferior capabilities of body, and the immune state of host is to affect the weight of Nasopharyngeal neoplasms
Wanting factor, weakened body resistance pathological examination is that tumor cell is survived in vivo;Poison--it is embodied in residual poison unclear, after operation, Radiotherapy chemotherapy still
The subclinical focus of remaining, becomes revivable, the root of transfer and relapse;The stasis of blood--be embodied in the Gao Ning of blood, high viscous and height is poly-
State;Expectorant is tied--it is embodied in propagation rapidly and the growth of attached wall, implantation and the metastatic tumor of micro-tumor bolt.Wind may be embodied in cancerous cell
Easy transfer characteristic.
About the tumor-blood-vessel growth of one of neoplasm metastasis main mechanism, inventors believe that it belongs to motherland's medical science " network
Sick " category.The concept of the traditional Chinese medical science " network " is in form with functionally similar to microcirculation concept to the blood capillary of modern medicine, and motherland cures
Think, channels is the branch of channel system, just as network, crisscross, throughout whole body, and interior network the five internal organs, outer even podomere, have
The physiological functions such as through the exterior and the interior is upper and lower, circulation qi-blood-body fluid, infiltrating irrigation internal organs.As " Ling Shu Miraculous Pivot or Divine Axis passages through which vital energy circulates " is sayed: " passages through which vital energy circulates 12
Person, between volt row boundary between muscles, loses deeply ... the floating and common person of all feeling pulse, all channels are also." under normal circumstances, channels system is made
For linking up inside and outside body, maintain equilibrium between yin and yang, ensureing the functional network that internal organs QI and blood irrigates, also it is to coordinate body internal and external environment
The unified important feature maintaining body homeostasis, for maintaining human normal vital movement tool to be of great significance;But
Under various pathological states, the regulatory mechanism such as tumour patient angiogenesis factor is not normal, causes body imbalance between YIN and YANG, performance
Then increasing for angiogenic factors secretion in tumor-blood-vessel growth process, and inhibitive factor secretion reduces, angiogenesis is just
Negative growth factor is unbalance, causes this functional network system structure, distribution and function that significantly change occurs, shows as network body
Tortuous, expansion, channels abnormal distribution, cause local meridian qi and blood body fluid to dredge cloth and irrigate not normal, the internal organs of its network genus, tissue, device
A series of channels such as official's 26S Proteasome Structure and Function is abnormal block the disease being characterized.This is microcirculatory with tumour patient focus local morbid state
Set up very much like.Therefore, the Angiogenesis process of tumor, namely the traditional Chinese medical science it " pathogen usually intruding into collateral in protracted disease ", " obstruction of collateral caused by windphlegm (evil poison stream
Note) " and form the process of channels pathological changes.Its pathogenesis initiating agent is healthy energy deficiency in origin, accumulates in cancer poison, and its pathogenesis evolution process is cancer
Accumulate with the passing of time in poison, vital QI cannot conquer pathogen, cause internal organs, negative and positive, QI and blood functional disorder, body homeostasis structural deterioration, and the damage of channels
Wound is the main pathological product of its pathogenesis evolution process, be again its pathological changes gradually deeply, become sick and all cause the state of an illness further
The approach deteriorated and essential condition.Due to carcinoma local channels structure, distribution, dysfunction so that cancer heresy is prone to invade venation,
Cancer heresy once enters network visitor's arteries and veins, affects the operation of QI and blood in network and the defeated cloth of body fluid, causes network to lose unobstructed, and infiltrating irrigation is not normal, causes cancer
Poison, the stagnant network of blood stasis, the pathological change such as cause in network in various degree the stagnation of QI, blood stasis or Tianjin solidifying, with the passing of time prolong void, empty gas is detained, blood
Stasis of blood Tianjin is solidifying etc. interacts, and knot is the most sick mutually, accumulates in the course of time and accumulates poison, poison consumed pulse network, alters by ecchymosis perverse and unreasonable manner, ruins internal organs, damage body.This
Evolution process has fully demonstrated empty stagnant, the expectorant stasis of blood, poison this basic pathology of consumed pulse network change, for pathogenic factor gradually deeply, vital QI being weakened and pathogen being violent,
A kind of pathological state that patient's condition is deadlocked, and thus cause the prolonged difficulty of canceration more, gradually become obstinate disease.
In view of to above neoplasm metastasis and the heightened awareness of angiogenesis pathogenic characteristic thereof, focus on " prevention of diseae " in clinic
" preventing exacerbation after being taken ill " " " under thought guidance, present inventors believe that tumor is a systemic disease, transfer is its generalization to preventive treatment of disease
Concrete manifestation;Healthy energy virtual loss, the most not pressing down heresy is the basic reason that neoplasm metastasis occurs;Propose the blood stasis due to qi deficiency of transfer, expectorant
The poison theory of pathogenesis such as multiple abscess, obstruction of collateral caused by windphlegm, the pathogenesis development law of transfer is healthy energy virtual loss, accumulates in evil poison, and stirring-up of pathogenic wind in the interior resulting from deficiency, wind is held under the arm
Expectorant poison, multiple abscess meridians, the stasis of blood forms long-pending.Clinical application is many starts with in terms of void, the stasis of blood, poison, expectorant, wet, wind etc., evident in efficacy.This medicine
Thing is i.e. on above experiential basis, in conjunction with the modern study achievement of tumor-blood-vessel growth and transfer, at treatment must aim at the pathogenesis of disease, giving consideration to both the incidental and fundamental
And under strengthening vital QI to eliminate pathogenic factors principle instructs, with " " Fuzheng Huoxue, detoxicating and resolving stagnation of pathogens, calming wind and dredging collateral " as the rule for the treatment of, it then follows prescription combination principle, essence
The compound pure Chinese medicine preparation with antitumor, metastasis effect of heart prescription.
Therefore treatment must aim at the pathogenesis of disease, giving consideration to both the incidental and fundamental, strengthening vital QI to eliminate pathogenic factors principle instruct under according to transfer and angiogenesis void, the stasis of blood, poison,
Expectorant, knot, the basic pathology change of wind, in conjunction with clinical practice for many years, present inventors have proposed that " " Fuzheng Huoxue, relieves dizziness, high fever, infantile convulsions, epilepsy, etc. at detoxicating and resolving stagnation of pathogens
Dredging collateral " method for the treatment of, and meticulously prescription, repeatedly practise and grope, having createed compound Chinese medicinal preparation, to by with operation, change
Treatment, the connected applications of radiotherapy means, from the function of internal organs, negative and positive, QI and blood and the meridians of integrally-regulated body, by shifting
Journey Mutiple Targets regulation " reducing for the excess syndrome, tonifying for deficiency syndrome ", checks tumor-blood-vessel growth, and cut-out tumors of nutrients, route of metastasis reach anti-
Tumor, the purpose of metastasis.
Detailed description of the invention
Embodiment 1, a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, including following component
Crude drug:
Radix Astragali 45g, Fructus Ligustri Lucidi 15g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 10g, Semen Coicis 18g, Herba Scutellariae Barbatae 20g, cowherb
Art 20g, Scorpio 10g, Spina Gleditsiae 10g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Glycyrrhizae Preparata 6g.
Preparation method: medical material clear water soaks half an hour, after big fire is boiled, then slow fire boiling 40 minutes, take head and decoct, then add
Soak by water 30 minutes, takes two and decocts, and two decoct and even, and a point morning and evening takes for twice.
Embodiment 2, a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, including following component
Crude drug:
Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 15g, Pericarpium Citri Reticulatae 15g, Endothelium Corneum Gigeriae Galli 18g, Semen Coicis 30g, Herba Scutellariae Barbatae 30g, cowherb
Art 30g, Scorpio 15g, Spina Gleditsiae 15g, Concha Ostreae 60g, Carapax Trionycis 20g, Ramulus Uncariae Cum Uncis 15g, Radix Glycyrrhizae Preparata 10g.
Preparation method:
(1) extract: after above-mentioned all medicines are weighed by weight, add deionized water and soak 30 minutes, decoct twice, 45 points first
Clock, filters, and retains filtrate.The soak by water of medicinal residues addition 4-5 times amount 30 minutes, merging filtrate after filtration, it is condensed into 1:1.Add
95% ethanol, stirring while adding, make alcohol content reach 70%, stand and make precipitation.Taking supernatant, heating concentrates as extractum standby.
(2) soft material is prepared: add sucrose, dextrin, mixing, add appropriate 95% ethanol, stirring while adding, become soft material, in
50 DEG C of oven dryings are standby after 15 minutes.
(3) granulate: cross 16 mesh sieves, subpackage.
Embodiment 3, a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, including following component
Crude drug:
Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, cowherb
Art 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Glycyrrhizae Preparata 6g.
Preparation method: after being weighed by weight by above-mentioned all medicines, adds deionized water and soaks 30 minutes, decoct twice, and first 45
Minute, filter, retain filtrate.The soak by water of medicinal residues addition 4-5 times amount 30 minutes, merging filtrate after filtration, it is condensed into 1:1, cold
Adding the ethanol of 1.5 times amount the most afterwards, fully mix, stand overnight, take supernatant, precipitate is cleaned with a small amount of 95% ethanol, washing liquid
Merging with filtrate, after decompression recycling ethanol, concentrate cooling and stand, after filtration, vacuum and low temperature is concentrated into thick paste, and thick paste proportion is
1.33 are spray-dried finely ground mistake 300 mesh sieve, obtain extract powder, fill and make capsule.
Embodiment 4, a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, including following component
Crude drug:
Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, cowherb
Art 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Glycyrrhizae Preparata 6g, Radix Platycodonis 10g, Semen Armeniacae Amarum 10g.
Preparation method: be dried according to after above-mentioned weight weighting raw materials, microgranule more than micronizing to 800 mesh, adds
Appropriate dextrin makes tablet after stirring.
Embodiment 5, a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, including following component
Crude drug:
Radix Astragali 45g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, cowherb
Art 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Glycyrrhizae Preparata 6g, Rhizoma Atractylodis Macrocephalae 10g, Poria 15g, benefit
Bone fat 30g.
Preparation method: with embodiment 1.
Embodiment 6, a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, including following component
Crude drug:
Radix Astragali 45g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, cowherb
Art 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Glycyrrhizae Preparata 6g, Rhizoma Atractylodis Macrocephalae 10g, Poria 15g, benefit
Bone fat 30g, Bulbus Fritillariae Uninbracteatae 15g, Radix Platycodonis 10g, Fructus Trichosanthis 30g.
Preparation method: with embodiment 1.
Embodiment 7, a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, including following component
Crude drug:
Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, cowherb
Art 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Glycyrrhizae Preparata 6g, Radix Bupleuri 10g, Radix Curcumae 10g, perfume (or spice)
Attached 10g, Radix Angelicae Dahuricae 10g, Rhizoma Chuanxiong 10g.
Preparation method: with embodiment 2.
Embodiment 8, a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, including following component
Crude drug:
Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, cowherb
Art 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Glycyrrhizae Preparata 6g, Radix Sanguisorbae 15g, Herba Patriniae 15g,
Caulis Sargentodoxae 10g.
Preparation method: with embodiment 3.
Embodiment 9, a kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, including following component
Crude drug:
Radix Astragali 60g, Fructus Ligustri Lucidi 30g, Rhizoma Pinelliae 10g, Pericarpium Citri Reticulatae 10g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 30g, Herba Scutellariae Barbatae 13g, cowherb
Art 30g, Scorpio 10g, Spina Gleditsiae 15g, Concha Ostreae 30g, Carapax Trionycis 10g, Ramulus Uncariae Cum Uncis 10g, Radix Glycyrrhizae Preparata 6g, Radix Bupleuri 10g, Fructus Aurantii 5g, white
Chinese herbaceous peony 10g.
Preparation method: with embodiment 2.
Claims (9)
1. the Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift, is characterized in that, in parts by weight, including
The crude drug of following component: the Radix Astragali 45~60 parts, Fructus Ligustri Lucidi 15~30 parts, the Rhizoma Pinelliae 10~15 parts, Pericarpium Citri Reticulatae 10~15 parts, Endothelium Corneum Gigeriae Galli
10~18 parts, Semen Coicis 18~30 parts, Herba Scutellariae Barbatae 20~30 parts, Rhizoma Curcumae 20~30 parts, Scorpio 10~15 parts, Spina Gleditsiae 10~
15 parts, Concha Ostreae 30~60 parts, Carapax Trionycis 10~20 parts, Ramulus Uncariae Cum Uncis 10~15 parts, Radix Glycyrrhizae Preparata 6~10 parts.
The Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift the most as claimed in claim 1, is characterized in that, with
Weight portion meter, including the crude drug of following component: the Radix Astragali 60 parts, Fructus Ligustri Lucidi 30 parts, the Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli 15
Part, Semen Coicis 30 parts, Herba Scutellariae Barbatae 13 parts, Rhizoma Curcumae 30 parts, Scorpio 10 parts, Spina Gleditsiae 15 parts, Concha Ostreae 30 parts, Carapax Trionycis 10 parts,
Ramulus Uncariae Cum Uncis 10 parts, Radix Glycyrrhizae Preparata 6 parts.
The Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift the most as claimed in claim 1 or 2, is characterized in that,
In parts by weight, including the crude drug of following component: the Radix Astragali 60 parts, Fructus Ligustri Lucidi 30 parts, the Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli
15 parts, Semen Coicis 30 parts, Herba Scutellariae Barbatae 13 parts, Rhizoma Curcumae 30 parts, Scorpio 10 parts, Spina Gleditsiae 15 parts, Concha Ostreae 30 parts, Carapax Trionycis 10
Part, Ramulus Uncariae Cum Uncis 10 parts, Radix Glycyrrhizae Preparata 6 parts, Radix Platycodonis 10 parts, 10 parts of Semen Armeniacae Amarum.
The Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift the most as claimed in claim 1 or 2, is characterized in that,
In parts by weight, including the crude drug of following component: the Radix Astragali 45 parts, Fructus Ligustri Lucidi 30 parts, the Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli
15 parts, Semen Coicis 30 parts, Herba Scutellariae Barbatae 13 parts, Rhizoma Curcumae 30 parts, Scorpio 10 parts, Spina Gleditsiae 15 parts, Concha Ostreae 30 parts, Carapax Trionycis 10
Part, Ramulus Uncariae Cum Uncis 10 parts, Radix Glycyrrhizae Preparata 6 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, 15 parts of Poria, Fructus Psoraleae 30 parts.
The Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift the most as claimed in claim 1 or 2, is characterized in that,
In parts by weight, including the crude drug of following component: the Radix Astragali 45 parts, Fructus Ligustri Lucidi 30 parts, the Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli
15 parts, Semen Coicis 30 parts, Herba Scutellariae Barbatae 13 parts, Rhizoma Curcumae 30 parts, Scorpio 10 parts, Spina Gleditsiae 15 parts, Concha Ostreae 30 parts, Carapax Trionycis 10
Part, Ramulus Uncariae Cum Uncis 10 parts, Radix Glycyrrhizae Preparata 6 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, 15 parts of Poria, Fructus Psoraleae 30 parts, Bulbus Fritillariae Uninbracteatae 15 parts, Radix Platycodonis 10 parts, Fructus Trichosanthis 30
Part.
The Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift the most as claimed in claim 1 or 2, is characterized in that,
In parts by weight, including the crude drug of following component: the Radix Astragali 60 parts, Fructus Ligustri Lucidi 30 parts, the Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli
15 parts, Semen Coicis 30 parts, Herba Scutellariae Barbatae 13 parts, Rhizoma Curcumae 30 parts, Scorpio 10 parts, Spina Gleditsiae 15 parts, Concha Ostreae 30 parts, Carapax Trionycis 10
Part, Ramulus Uncariae Cum Uncis 10 parts, Radix Glycyrrhizae Preparata 6 parts, Radix Bupleuri 10 parts, Radix Curcumae 10 parts, Rhizoma Cyperi 10 parts, the Radix Angelicae Dahuricae 10 parts, Rhizoma Chuanxiong 10 parts.
The Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift the most as claimed in claim 1 or 2, is characterized in that,
In parts by weight, including the crude drug of following component: the Radix Astragali 60 parts, Fructus Ligustri Lucidi 30 parts, the Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli
15 parts, Semen Coicis 30 parts, Herba Scutellariae Barbatae 13 parts, Rhizoma Curcumae 30 parts, Scorpio 10 parts, Spina Gleditsiae 15 parts, Concha Ostreae 30 parts, Carapax Trionycis 10
Part, Ramulus Uncariae Cum Uncis 10 parts, Radix Glycyrrhizae Preparata 6 parts, Radix Sanguisorbae 15 parts, Herba Patriniae 15 parts, Caulis Sargentodoxae 10 parts.
The Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift the most as claimed in claim 1 or 2, is characterized in that,
In parts by weight, including the crude drug of following component: the Radix Astragali 60 parts, Fructus Ligustri Lucidi 30 parts, the Rhizoma Pinelliae 10 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli
15 parts, Semen Coicis 30 parts, Herba Scutellariae Barbatae 13 parts, Rhizoma Curcumae 30 parts, Scorpio 10 parts, Spina Gleditsiae 15 parts, Concha Ostreae 30 parts, Carapax Trionycis 10
Part, Ramulus Uncariae Cum Uncis 10 parts, Radix Glycyrrhizae Preparata 6 parts, Radix Bupleuri 10 parts, Fructus Aurantii 5 parts, the Radix Paeoniae Alba 10 parts.
9. described in claim 1, suppress the preparation method of the Chinese medicine composition of tumor-blood-vessel growth, anti-tumor transfer, its feature
It is that step is as follows
(1) extract: after above-mentioned all medicines are weighed by weight, add deionized water and soak 30 minutes, decoct twice, 45 minutes first,
Filter, retain filtrate;The soak by water of medicinal residues addition 4-5 times amount 30 minutes, merging filtrate after filtration, it is condensed into 1:1;Add 95%
Ethanol, stirring while adding, make alcohol content reach 70%, stand and make precipitation;Taking supernatant, heating concentrates as extractum standby;
(2) soft material is prepared: add sucrose, dextrin, mixing, add appropriate 95% ethanol, stirring while adding, become soft material, in 50 DEG C
Oven drying is standby after 15 minutes;
(3) granulate: cross 16 mesh sieves, subpackage.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610575042.7A CN106110186A (en) | 2016-07-21 | 2016-07-21 | A kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610575042.7A CN106110186A (en) | 2016-07-21 | 2016-07-21 | A kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106110186A true CN106110186A (en) | 2016-11-16 |
Family
ID=57290781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610575042.7A Pending CN106110186A (en) | 2016-07-21 | 2016-07-21 | A kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106110186A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107029188A (en) * | 2017-06-08 | 2017-08-11 | 厦门大学 | One kind reduction tumor patient recurrence rate Chinese medicine compound prescription |
CN112316049A (en) * | 2020-12-04 | 2021-02-05 | 天津河西区天医缘中医门诊有限公司 | Traditional Chinese medicine decoction and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103417907A (en) * | 2012-05-26 | 2013-12-04 | 石家庄以岭药业股份有限公司 | Applications of traditional Chinese medicine composition in preparation of drug used for inhibiting angiogenesis |
-
2016
- 2016-07-21 CN CN201610575042.7A patent/CN106110186A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103417907A (en) * | 2012-05-26 | 2013-12-04 | 石家庄以岭药业股份有限公司 | Applications of traditional Chinese medicine composition in preparation of drug used for inhibiting angiogenesis |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107029188A (en) * | 2017-06-08 | 2017-08-11 | 厦门大学 | One kind reduction tumor patient recurrence rate Chinese medicine compound prescription |
CN107029188B (en) * | 2017-06-08 | 2020-06-19 | 厦门大学 | Traditional Chinese medicine compound for reducing recurrence rate of tumor patients |
CN112316049A (en) * | 2020-12-04 | 2021-02-05 | 天津河西区天医缘中医门诊有限公司 | Traditional Chinese medicine decoction and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100518807C (en) | A Medicine for treatment of ascites due to cirrhosis | |
CN105749179A (en) | Traditional Chinese medicine composition for treating metabolic syndrome | |
CN104740546A (en) | Traditional Chinese medicine composition for treating gastric cancer | |
CN104082745B (en) | For the conditioning of blood stasis body constitution and the medicated diet and the preparation method that improve immunoregulation capability | |
CN104524335A (en) | Pill for conditioning female endocrine disorders and preparation method of pill | |
CN104043057A (en) | Traditional Chinese medicinal composition for treating lymph cancer | |
CN104083728B (en) | The processing method of anticancer dispersing tumor concentrated pill | |
CN101564464B (en) | Chinese medicament for adjusting organism immunity of tumor patients | |
CN106110186A (en) | A kind of Chinese medicine composition suppressing tumor-blood-vessel growth, anti-tumor to shift | |
CN103285343B (en) | Medicine for treating liver cancer and preparation method thereof | |
CN103610936B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of coronary heart disease | |
CN104800510A (en) | Traditional Chinese medicine composition for treating stomach cancer | |
CN103536849A (en) | Drug for treating pulmonary embolism and preparation method thereof | |
CN102861292B (en) | Medicament for treating esophageal cancer and preparation method thereof | |
CN105233174A (en) | Traditional Chinese medicine composition for painlessly removing gall stone and taking method | |
CN104771660A (en) | Chinese traditional medicine preparation for treatment of gastric cancer and preparation method thereof | |
CN104623544A (en) | Traditional Chinese medicine preparation capable of tonifying spleen and eliminating dampness for treating moderate fatty liver and preparation method of traditional Chinese medicine preparation | |
CN103610893A (en) | Traditional Chinese medicine for treating coronary disease | |
CN104825795A (en) | Traditional Chinese medicinal capsule for treating arrhythmia | |
CN103432335B (en) | Medicament for treating chyluria and preparation method thereof | |
CN103285130B (en) | Chinese medicine composition for liver cancer treatment and preparing method thereof | |
CN102274358B (en) | Traditional Chinese medicine for treating premature menstruation, profuse menstruation, breast distending pain and large clot quantity | |
CN102526625B (en) | Medicament for treating hepatitis B and preparation method for medicament | |
CN106362074A (en) | Novel traditional Chinese medicine composition for treating anorexia and preparation method thereof | |
CN106334140A (en) | Traditional Chinese medicine composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161116 |